The Estée Lauder Companies Inc. (EL) 10-Q 3 May 21 2021 Q3 Quarterly report Financial data

COVER PAGE

COVER PAGE - shares	9 Months Ended
	Mar. 31, 2021	Apr. 26, 2021
Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2021
Document Transition Report	false
Entity File Number	1-14064
Entity Registrant Name	Estée Lauder Companies Inc
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	11-2408943
Entity Address, Address Line One	767 Fifth Avenue
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10153
City Area Code	212
Local Phone Number	572-4200
Title of 12(b) Security	Class A Common Stock, $.01 par value
Trading Symbol	EL
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Current Fiscal Year End Date	--06-30
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q3
Entity Central Index Key	0001001250
Amendment Flag	false
Common Class A
Entity Information [Line Items]
Entity Common Stock, Shares Outstanding		231,894,845
Common Class B
Entity Information [Line Items]
Entity Common Stock, Shares Outstanding		130,617,029

CONSOLIDATED STATEMENTS OF EARN

CONSOLIDATED STATEMENTS OF EARNINGS (LOSS) - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Mar. 31, 2021	Mar. 31, 2020
Income Statement [Abstract]
Net sales	$ 3,864	$ 3,345	$ 12,279	$ 11,864
Cost of sales	939	836	2,848	2,785
Gross profit	2,925	2,509	9,431	9,079
Operating expenses
Selling, general and administrative	2,145	2,030	6,761	6,753
Restructuring and other charges	131	24	172	54
Goodwill impairment	0	275	54	786
Impairment of other intangible and long-lived assets	33	71	60	337
Total operating expenses	2,309	2,400	7,047	7,930
Operating income	616	109	2,384	1,149
Interest expense	43	42	131	112
Interest income and investment income, net	9	14	40	41
Other components of net periodic benefit cost	2	1	12	3
Other income	0	0	0	576
Earnings before income taxes	580	80	2,281	1,651
Provision for income taxes	122	84	421	496
Net earnings (loss)	458	(4)	1,860	1,155
Net earnings attributable to noncontrolling interests	(2)	(2)	(8)	(9)
Net earnings (loss) attributable to The Estée Lauder Companies Inc.	$ 456	$ (6)	$ 1,852	$ 1,146
Net earnings (loss) attributable to The Estée Lauder Companies Inc. per common share
Basic (in dollars per share)	$ 1.25	$ (0.02)	$ 5.10	$ 3.18
Diluted (in dollars per share)	$ 1.24	$ (0.02)	$ 5.03	$ 3.12
Weighted-average common shares outstanding
Basic (in shares)	363.6	360.2	362.9	360.6
Diluted (in shares)	369	360.2	368.1	367.1

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Mar. 31, 2021	Mar. 31, 2020
Statement of Comprehensive Income [Abstract]
Net earnings (loss)	$ 458	$ (4)	$ 1,860	$ 1,155
Other comprehensive income (loss):
Net cash flow hedge gain (loss)	41	34	(16)	10
Retirement plan and other retiree benefit adjustments	7	6	19	16
Translation adjustments	(121)	(185)	170	(191)
Benefit (provision) for income taxes on components of other comprehensive income	(32)	2	6	15
Total other comprehensive income (loss), net of tax	(105)	(143)	179	(150)
Comprehensive income (loss)	353	(147)	2,039	1,005
Comprehensive income attributable to noncontrolling interests:
Net earnings	(2)	(2)	(8)	(9)
Translation adjustments	1	0	(1)	1
Comprehensive income attributable to noncontrolling interests	(1)	(2)	(9)	(8)
Comprehensive income (loss) attributable to The Estée Lauder Companies Inc.	$ 352	$ (149)	$ 2,030	$ 997

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Mar. 31, 2021	Jun. 30, 2020
Current assets
Cash and cash equivalents	$ 6,399	$ 5,022
Accounts receivable, net	1,735	1,194
Inventory and promotional merchandise	2,134	2,062
Prepaid expenses and other current assets	729	614
Total current assets	10,997	8,892
Property, plant and equipment, net	2,106	2,055
Other assets
Operating lease right-of-use assets	2,212	2,282
Goodwill	1,369	1,401
Other intangible assets, net	2,294	2,338
Other assets	922	813
Total other assets	6,797	6,834
Total assets	19,900	17,781
Current liabilities
Current debt	471	1,222
Accounts payable	1,277	1,177
Operating lease liabilities	372	375
Other accrued liabilities	3,077	2,405
Total current liabilities	5,197	5,179
Noncurrent liabilities
Long-term debt	5,487	4,914
Long-term operating lease liabilities	2,198	2,278
Other noncurrent liabilities	1,460	1,448
Total noncurrent liabilities	9,145	8,640
Contingencies
Equity
Common stock, $.01 par value; Class A shares authorized: 1,300,000,000 at March 31, 2021 and June 30, 2020; shares issued: 459,687,905 at March 31, 2021 and 451,927,441 at June 30, 2020; Class B shares authorized: 304,000,000 at March 31, 2021 and June 30, 2020; shares issued and outstanding: 130,617,029 at March 31, 2021 and 135,235,429 at June 30, 2020	6	6
Paid-in capital	5,231	4,790
Retained earnings	11,420	10,134
Accumulated other comprehensive loss	(487)	(665)
Stockholders' equity before treasury stock	16,170	14,265
Less: Treasury stock, at cost; 227,738,087 Class A shares at March 31, 2021 and 226,637,238 Class A shares at June 30, 2020	(10,642)	(10,330)
Total stockholders’ equity – The Estée Lauder Companies Inc.	5,528	3,935
Noncontrolling interests	30	27
Total equity	5,558	3,962
Total liabilities and equity	$ 19,900	$ 17,781

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Mar. 31, 2021	Jun. 30, 2020
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Treasury stock, shares	227,738,087	226,637,238
Common Class A
Common stock, shares authorized	1,300,000,000	1,300,000,000
Common stock, shares issued	459,687,905	451,927,441
Common Class B
Common stock, shares authorized	304,000,000	304,000,000
Common stock, shares issued	130,617,029	135,235,429
Common stock, shares outstanding	130,617,029	135,235,429

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	9 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Cash flows from operating activities
Net earnings	$ 1,860	$ 1,155
Adjustments to reconcile net earnings to net cash flows from operating activities:
Depreciation and amortization	475	447
Deferred income taxes	(103)	(65)
Non-cash stock-based compensation	255	210
Net loss on disposal of property, plant and equipment	19	6
Non-cash restructuring and other charges	97	19
Pension and post-retirement benefit expense	75	62
Pension and post-retirement benefit contributions	(35)	(54)
Goodwill, other intangible and long-lived asset impairments	114	1,123
Changes in fair value of contingent consideration	(2)	(9)
Gain on previously held equity method investment	0	(553)
Other non-cash items	(17)	(11)
Changes in operating assets and liabilities:
Increase in accounts receivable, net	(506)	(48)
Decrease (increase) in inventory and promotional merchandise	13	(41)
Increase in other assets, net	(122)	(63)
Increase (decrease) in accounts payable	55	(317)
Increase in other accrued and noncurrent liabilities	629	62
Increase (decrease) in operating lease assets and liabilities, net	(30)	22
Net cash flows provided by operating activities	2,777	1,945
Cash flows from investing activities
Capital expenditures	(386)	(468)
Proceeds from purchase price refund	32	0
Payments for acquired businesses, net of cash acquired	(8)	(1,047)
Purchases of investments	(40)	(5)
Settlement of net investment hedges	(175)	(37)
Net cash flows used for investing activities	(577)	(1,557)
Cash flows from financing activities
Proceeds (repayments) of current debt, net	(746)	1,514
Proceeds from issuance of long-term debt, net	596	1,783
Debt issuance costs	(4)	(14)
Repayments and redemptions of long-term debt	(6)	(511)
Proceeds from stock-based compensation transactions	180	148
Payments to acquire treasury stock	(316)	(883)
Payments of contingent consideration	0	(3)
Dividends paid to stockholders	(561)	(502)
Payments to noncontrolling interest holders for dividends	(5)	(7)
Net cash flows provided by (used for) financing activities	(862)	1,525
Effect of exchange rate changes on Cash and cash equivalents	39	(24)
Net increase in Cash and cash equivalents	1,377	1,889
Cash and cash equivalents at beginning of period	5,022	2,987
Cash and cash equivalents at end of period	$ 6,399	$ 4,876

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Mar. 31, 2021
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying consolidated financial statements include the accounts of The Estée Lauder Companies Inc. and its subsidiaries (collectively, the “Company”). All significant intercompany balances and transactions have been eliminated. The unaudited interim consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The unaudited interim consolidated financial statements furnished reflect all adjustments which are, in the opinion of management, necessary for a fair statement of the results for the interim periods presented. The results of operations of any interim period are not necessarily indicative of the results of operations to be expected for the full fiscal year. The interim consolidated financial statements should be read in conjunction with the consolidated financial statements and accompanying footnotes included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2020. Certain amounts in the consolidated financial statements of prior years have been reclassified to conform to current year presentation. Management Estimates The preparation of financial statements and related disclosures in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses reported in those financial statements. Descriptions of the Company’s significant accounting policies are discussed in the notes to consolidated financial statements in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2020. Management evaluates the related estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and makes adjustments when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ significantly from those estimates and assumptions. Significant changes, if any, in those estimates and assumptions resulting from continuing changes in the economic environment, including those related to the impacts of the COVID-19 pandemic, will be reflected in the consolidated financial statements in future periods. Currency Translation and Transactions All assets and liabilities of foreign subsidiaries and affiliates are translated at period-end rates of exchange, while revenue and expenses are translated at monthly average rates of exchange for the period. Unrealized translation gains (losses), net of tax, reported as translation adjustments through other comprehensive income (loss) (“OCI”) attributable to The Estée Lauder Companies Inc. were $(143) million and $(173) million, net of tax, during the three months ended March 31, 2021 and 2020, respectively, and $175 million and $(170) million, net of tax, during the nine months ended March 31, 2021 and 2020, respectively. For the Company’s subsidiaries operating in highly inflationary economies, the U.S. dollar is the functional currency. Remeasurement adjustments in financial statements in a highly inflationary economy and other transactional gains and losses are reflected in earnings (loss). These subsidiaries are not material to the Company’s consolidated financial statements or liquidity. The Company enters into foreign currency forward contracts and may enter into option contracts to hedge foreign currency transactions for periods consistent with its identified exposures. The Company also enters into foreign currency forward contracts to hedge a portion of its net investment in certain foreign operations, which are designated as net investment hedges. See Note 6 – Derivative Financial Instruments for further discussion . The Company categorizes these instruments as entered into for purposes other than trading. The accompanying consolidated statements of earnings (loss) include net exchange gains (losses) on foreign currency transactions of $(3) million and $15 million during the three months ended March 31, 2021 and 2020, respectively, and $(5) million and $40 million during the nine months ended March 31, 2021 and 2020, respectively. Concentration of Credit Risk The Company is a worldwide manufacturer, marketer and distributor of skin care, makeup, fragrance and hair care products. The Company’s sales subject to credit risk are made primarily to department stores, perfumeries, specialty multi-brand retailers and retailers in its travel retail business. The Company grants credit to qualified customers. As a result of the COVID-19 pandemic, the Company has enhanced its assessment of its customers' abilities to pay with a greater focus on factors affecting their liquidity and less on historical payment performance. While the Company does not believe it is exposed significantly to any undue concentration of credit risk at this time, it continues to monitor the extent of the impact of the COVID-19 pandemic on its customers' abilities, individually and collectively, to make timely payments. The Company’s largest customer during the three and nine months ended March 31, 2021 sells products primarily in China travel retail. This customer accounted for $690 million or 18%, and $143 million or 4% for the three months ended March 31, 2021 and 2020, respectively, and $1,898 million or 15% and $608 million or 5% for the nine months ended March 31, 2021 and 2020, respectively, of the Company's consolidated net sales. This customer accounted for $366 million, or 21%, and $297 million, or 24%, of the Company's accounts receivable at March 31, 2021 and June 30, 2020, respectively. Another major customer of the Company during the quarter sells products primarily within the United States and accounted for $179 million, or 10%, and $87 million, or 7%, of the Company’s accounts receivable at March 31, 2021 and June 30, 2020, respectively. This customer accounted for $167 million, or 4%, and $149 million, or 4%, for the three months ended March 31, 2021 and 2020, respectively, and $510 million or 4% and $589 million or 5% for the nine months ended March 31, 2021 and 2020, respectively, of the Company’s consolidated net sales. Inventory and Promotional Merchandise Inventory and promotional merchandise consists of the following: (In millions) March 31 June 30 Raw materials $ 551 $ 542 Work in process 282 305 Finished goods 1,078 995 Promotional merchandise 223 220 $ 2,134 $ 2,062 Property, Plant and Equipment Property, plant and equipment consists of the following: (In millions) March 31 June 30 Assets (Useful Life) Land $ 56 $ 33 Buildings and improvements (10 to 40 years) 467 400 Machinery and equipment (3 to 10 years) 946 865 Computer hardware and software (4 to 10 years) 1,374 1,335 Furniture and fixtures (5 to 10 years) 121 120 Leasehold improvements 2,397 2,381 5,361 5,134 Less accumulated depreciation and amortization (3,255) (3,079) $ 2,106 $ 2,055 The cost of assets related to projects in progress of $581 million and $501 million as of March 31, 2021 and June 30, 2020, respectively, is included in their respective asset categories above. Depreciation and amortization of property, plant and equipment was $129 million and $131 million during the three months ended March 31, 2021 and 2020, respectively, and $380 million and $383 million during the nine months ended March 31, 2021 and 2020, respectively. Depreciation and amortization related to the Company’s manufacturing process is included in Cost of sales, and all other depreciation and amortization is included in Selling, general and administrative expenses in the accompanying consolidated statements of earnings (loss). Leases The Company recognized $33 million and $13 million of long-lived asset impairments, included in Impairments of other intangible and long-lived assets, in the accompanying consolidated statements of earnings (loss) for the three and nine months ended March 31, 2021 and 2020, respectively. The fiscal 2021 impairments related to other assets (i.e. rights associated with commercial operating leases), operating lease right-of-use assets and the related property, plant and equipment in certain freestanding stores primarily in Europe, and the fiscal 2020 impairments related to operating lease right-of-use assets and the related property, plant and equipment in certain freestanding stores primarily in North America. In both periods, the impairments were due to the negative impacts of the COVID-19 pandemic. Income Taxes The effective rate for income taxes for the three and nine months ended March 31, 2021 and 2020 are as follows: Three Months Ended Nine Months Ended 2021 2020 2021 2020 Effective rate for income taxes 21.0 % 105.0 % 18.5 % 30.0 % Basis-point change from the prior-year period (8,400) (1,150) For the three and nine months ended March 31, 2021, the decrease in the effective tax rate was primarily attributable to the impact of nondeductible goodwill charges recognized in the three and nine months ended March 31, 2020 and a lower effective tax rate on the Company's foreign operations. The lower amount of earnings before income taxes for the three and nine months ended March 31, 2020 increased the impact of the nondeductible charges. The effective tax rate for the three and nine months ended March 31, 2021 included the impact of the U.S. government issuance of final global intangible low-taxed income (“GILTI”) tax regulations in July 2020 under the Tax Cuts and Jobs Act that provide for a high-tax exception to the GILTI tax. These regulations are retroactive to the original enactment of the GILTI tax provision, which includes the Company's 2019 and 2020 fiscal years. The Company has elected to apply the GILTI high-tax exception to fiscal 2021, 2020 and 2019. The election for fiscal 2021 resulted in reductions of 100 basis points and 110 basis points to the effective tax rates for the three and nine months ended March 31, 2021, respectively. The impact of the elections with respect to fiscal 2020 and 2019 was recognized as a discrete item in the provision for income taxes in the second and third quarters of fiscal 2021 and resulted in reductions of 30 basis points and 220 basis points to the effective tax rates for the three and nine months ended March 31, 2021, respectively. As of March 31, 2021 and June 30, 2020, the gross amount of unrecognized tax benefits, exclusive of interest and penalties, totaled $72 million and $70 million, respectively. The total amount of unrecognized tax benefits at March 31, 2021 that, if recognized, would affect the effective tax rate was $57 million. The total gross interest and penalties accrued related to unrecognized tax benefits during the three and nine months ended March 31, 2021 in the accompanying consolidated statements of earnings (loss) was $2 million and $3 million, respectively. The total gross accrued interest and penalties in the accompanying consolidated balance sheets at March 31, 2021 and June 30, 2020, was $16 million and $13 million, respectively. On the basis of the information available as of March 31, 2021, the Company does not expect significant changes to the total amount of unrecognized tax benefits within the next twelve months. Other Accrued Liabilities Other accrued liabilities consist of the following: (In millions) March 31 June 30 Advertising, merchandising and sampling $ 299 $ 256 Employee compensation 534 424 Deferred revenue 310 222 Payroll and other taxes 287 250 Accrued income taxes 327 208 Sales return accrual 270 212 Other 1,050 833 $ 3,077 $ 2,405 Recently Adopted Accounting Standards Measurement of Credit Losses on Financial Instruments (ASC Topic 326 – Financial Instruments – Credit Losses) (“ASC 326”) In June 2016, the Financial Accounting Standards Board (“FASB”) issued authoritative guidance that requires companies to utilize an impairment model for most financial assets measured at amortized cost and certain other financial instruments, which include trade and other receivables, loans and held-to-maturity debt securities, to record an allowance for credit risk based on expected losses rather than incurred losses. In addition, this guidance changes the recognition method for credit losses on available-for-sale debt securities, which can occur as a result of market and credit risk, and requires additional disclosures. In general, modified retrospective adoption will be required for all outstanding instruments that fall under this guidance. In November 2019, the FASB issued authoritative guidance (ASU 2019-11 – Codification Improvements to Topic 326, Financial Instruments – Credit Losses) that amends ASC Topic 326 to clarify, improve and amend certain aspects of this guidance, such as disclosures related to accrued interest receivables and the estimation of credit losses associated with financial assets secured by collateral. In February 2020, the FASB issued authoritative guidance (ASU 2020-02 – Financial Instruments – Credit Losses (Topic 326) and Leases (Topic 842)) that amends and clarifies Topic 326 and Topic 842. For Topic 326, the codification was updated to include the Securities and Exchange Commission staff interpretations associated with registrants engaged in lending activities. Effective for the Company – Fiscal 2021 first quarter. Impact on consolidated financial statements – On July 1, 2020, the Company adopted ASC 326. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements. See Note 8 – Revenue Recognition for further discussion. Goodwill and Other – Internal-Use Software (ASU 2018-15 – Intangibles – Goodwill and Other – Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract) In August 2018, the FASB issued authoritative guidance that permits companies to capitalize the costs incurred for setting up business systems that operate on cloud technology. The new guidance aligns the requirement for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The guidance does not affect the accounting for the service element of a hosting arrangement that is a service contract. Capitalized costs associated with a hosting arrangement that is a service contract must be amortized over the term of the hosting arrangement to the same line item in the income statement as the expense for fees for the hosting arrangement. Effective for the Company – Fiscal 2021 first quarter, with early adoption permitted in any interim period. This guidance can be adopted either retrospectively, or prospectively to all implementation costs incurred after the date of adoption. Impact on consolidated financial statements – On July 1, 2020, the Company adopted this guidance prospectively to all implementation costs incurred after the date of adoption. The adoption of this standard did not have a material impact on the Company's consolidated financial statements. Recently Issued Accounting Standards Reference Rate Reform (ASC Topic 848) In March 2020, the FASB issued authoritative guidance to provide optional relief for companies preparing for the discontinuation of interest rates such as the London Interbank Offered Rate (“LIBOR”), which is expected to be phased out at the end of calendar 2021, and applies to lease contracts, hedging instruments, held-to-maturity debt securities and debt arrangements that have LIBOR as the benchmark rate. In January 2021, the FASB issued authoritative guidance that makes amendments to the new rules on accounting for reference rate reform. The amendments clarify that for all derivative instruments affected by the changes to interest rates used for discounting, margining or contract price alignment, regardless of whether they reference LIBOR or another rate expected to be discontinued as a result of reference rate reform, an entity may apply certain practical expedients in ASC Topic 848. Effective for the Company – This guidance can be applied for a limited time through December 31, 2022. The guidance will no longer be available to apply after December 31, 2022. Impact on consolidated financial statements – The Company is currently assessing the impact of applying this guidance on its existing derivative contracts, leases and other arrangements, as well as when to adopt this guidance. Income Taxes (ASU 2019-12 – Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes) In December 2019, the FASB issued authoritative guidance that simplifies the accounting for income taxes by removing certain exceptions and making simplifications in other areas. Effective for the Company – Fiscal 2022 first quarter, with early adoption permitted in any interim period. If adopted early, the Company must adopt all the amendments in the same period. The amendments have differing adoption methods including retrospectively, prospectively and/or modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the fiscal year of adoption, depending on the specific change. Impact on consolidated financial statements – The Company is in the process of finalizing its evaluation and currently expects to record a cumulative adjustment of approximately $120 million as an increase to its fiscal 2022 opening retained earnings balance for deferred taxes related to a previously held equity method investment that became a foreign subsidiary. No other recently issued accounting pronouncements are expected to have a material impact on the Company’s consolidated financial statements.

ACQUISITION OF BUSINESS

ACQUISITION OF BUSINESS	9 Months Ended
	Mar. 31, 2021
Business Combinations [Abstract]
ACQUISITION OF BUSINESS	ACQUISITION OF BUSINESS On December 18, 2019, the Company acquired the remaining 66.66% equity interest in Have&Be Co. Ltd. (“Have & Be”), the global skin care company behind Dr. Jart+ and men’s grooming brand Do The Right Thing, for $1,268 million in cash. Based on the final purchase price and working capital adjustments, the Company estimated a refund receivable of $32 million that was outstanding as of June 30, 2020 and was received in the first quarter of fiscal 2021. The Company originally acquired a minority interest in Have & Be in December 2015, and that investment structure included a formula-based call option for the remaining equity interest. The original minority interest was accounted for as an equity method investment, which had a carrying value of $133 million at the acquisition date. The acquisition of the remaining equity interest in Have & Be was considered a step acquisition, whereby the Company remeasured the previously held equity method investment to its fair value of $682 million, resulting in the recognition of a gain of $549 million. The acquisition of the remaining equity interest also resulted in the recognition of a previously unrealized foreign currency gain of $4 million, which was reclassified from accumulated OCI. The total gain on the Company’s previously held equity method investment of $553 million is included in Other income in the accompanying consolidated statements of earnings (loss) for the nine months ended March 31, 2020. The fair value of the previously held equity method investment was determined based upon a valuation of the acquired business, as of the date of acquisition, using an equal weighting of the income and market approaches, utilizing estimated cash flows and a terminal value, discounted at a rate of return that reflects the relative risk of the cash flows, as well as valuation multiples derived from comparable publicly traded companies. The accounting for the Have & Be business combination was finalized as of June 30, 2020. The amount paid at closing was funded by cash on hand including the proceeds from the issuance of debt. In anticipation of the closing, the Company transferred cash to a foreign subsidiary for purposes of making the closing payment. As a result, the Company recognized a foreign currency gain of $23 million, which is also included in Other income in the accompanying consolidated statements of earnings (loss) for the nine months ended March 31, 2020. Further information is included in the notes to consolidated financial statements in the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2020.

GOODWILL AND OTHER INTANGIBLE A

GOODWILL AND OTHER INTANGIBLE ASSETS	9 Months Ended
	Mar. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
GOODWILL AND OTHER INTANGIBLE ASSETS	GOODWILL AND OTHER INTANGIBLE ASSETS The following table presents goodwill by product category and the related change in the carrying amount: (In millions) Skin Care Makeup Fragrance Hair Care Total Balance as of June 30, 2020 Goodwill $ 519 $ 1,210 $ 254 $ 389 $ 2,372 Accumulated impairments (95) (817) (26) (33) (971) 424 393 228 356 1,401 Goodwill acquired during the period — 6 — 4 10 Impairment charges (1) (54) (13) — — (67) Translation adjustments, goodwill 21 — 4 3 28 Translation adjustments, accumulated impairments (1) — — (2) (3) (34) (7) 4 5 (32) Balance as of March 31, 2021 Goodwill 540 1,216 258 396 2,410 Accumulated impairments (150) (830) (26) (35) (1,041) $ 390 $ 386 $ 232 $ 361 $ 1,369 (1) A goodwill impairment charge of $13 million was recorded in connection with the exit of the global distribution of BECCA products and is included in Restructuring and other charges in the accompanying consolidated statements of earnings (loss) for the three and nine months ended March 31, 2021. See Note 4 – Charges Associated with Restructuring and Other Activities for further information relating to the Post-COVID Business Acceleration Program. See “ Impairment Testing During the Nine Months Ended March 31, 2021 ” below for further information relating to fiscal 2021 impairment charges related to GLAMGLOW. Other intangible assets consist of the following: March 31, 2021 June 30, 2020 (In millions) Gross Accumulated Total Net Gross Accumulated Total Net Amortizable intangible assets: Customer lists and other $ 1,641 $ 564 $ 1,077 $ 1,590 $ 475 $ 1,115 License agreements 43 43 — 43 43 — $ 1,684 $ 607 1,077 $ 1,633 $ 518 1,115 Non-amortizable intangible assets: Trademarks and other 1,217 1,223 Total intangible assets $ 2,294 $ 2,338 The aggregate amortization expense related to amortizable intangible assets was $25 million and $23 million for the three months ended March 31, 2021 and 2020, respectively, and $77 million and $45 million for the nine months ended March 31, 2021 and 2020, respectively. The estimated aggregate amortization expense for the remainder of fiscal 2021 and for each of the next four fiscal years is as follows: Fiscal (In millions) 2021 2022 2023 2024 2025 Estimated aggregate amortization expense $ 24 $ 101 $ 100 $ 100 $ 100 Impairment Testing During the Nine Months Ended March 31, 2021 During November 2020, given the actual and the estimate of the potential future impacts relating to the uncertainty of the duration and severity of COVID-19 impacting the Company and lower than expected results from geographic expansion, the Company made further revisions to the internal forecasts relating to its GLAMGLOW reporting unit. The Company concluded that the changes in circumstances in this reporting unit triggered the need for an interim impairment review of its trademark and goodwill. These changes in circumstances were also an indicator that the carrying amounts of GLAMGLOW's long-lived assets, including customer lists, may not be recoverable. Accordingly, the Company performed an interim impairment test for the trademark and a recoverability test for the long-lived assets as of November 30, 2020. The Company concluded that the carrying value of the trademark for GLAMGLOW exceeded its estimated fair value, which was determined utilizing the relief-from-royalty method to determine discounted projected future cash flows, and recorded an impairment charge of $21 million. In addition, the Company concluded that the carrying value of the GLAMGLOW customer lists intangible asset was fully impaired and recorded an impairment charge of $6 million. The fair value of all other long-lived assets of GLAMGLOW exceeded their carrying values and were not impaired as of November 30, 2020. After adjusting the carrying values of the trademark and customer lists intangible assets, the Company completed an interim quantitative impairment test for goodwill and recorded a goodwill impairment charge of $54 million, reducing the carrying value of goodwill for the GLAMGLOW reporting unit to zero. The fair value of the GLAMGLOW reporting unit was based upon an equal weighting of the income and market approaches, utilizing estimated cash flows and a terminal value, discounted at a rate of return that reflects the relative risk of the cash flows, as well as valuation multiples derived from comparable publicly traded companies that are applied to operating performance of the reporting unit. The impairment charges for the nine months ended March 31, 2021 were reflected in the skin care product category and in the Americas region. As of March 31, 2021, the remaining carrying value of the trademark related to the GLAMGLOW reporting unit was $36 million. Impairment Testing During the Nine Months Ended March 31, 2020 During December 2019, given the continuing declines in prestige makeup, generally in North America, and the ongoing competitive activity, the Company’s Too Faced, BECCA and Smashbox reporting units made revisions to their internal forecasts concurrent with the Company's brand strategy review process. The Company concluded that the changes in circumstances in these reporting units triggered the need for an interim impairment review of their respective trademarks and goodwill. These changes in circumstances were also an indicator that the carrying amounts of their respective long-lived assets, including customer lists, may not be recoverable. Accordingly, the Company performed interim impairment tests for the trademarks and recoverability tests for the long-lived assets as of December 31, 2019. The Company concluded that the carrying amounts of the long-lived assets were recoverable. The Company also concluded that the carrying values of the trademarks exceeded their estimated fair values, which were determined utilizing the relief-from-royalty method to determine discounted projected future cash flows, and recorded impairment charges totaling $266 million for trademarks during the three months ended December 31, 2019. After adjusting the carrying value of the trademarks, the Company completed interim quantitative impairment tests for goodwill and recorded goodwill impairment charges for each of these reporting units, totaling $511 million during the three months ended December 31, 2019. The fair value of each reporting unit was based upon an equal weighting of the income and market approaches, utilizing estimated cash flows and a terminal value, discounted at a rate of return that reflects the relative risk of the cash flows, as well as valuation multiples derived from comparable publicly traded companies that are applied to operating performance of the reporting unit. During March 2020, given the actual and the estimate of the potential future impacts relating to the uncertainty of the duration and severity of COVID-19 impacting the Company, the Company made revisions to the internal forecasts relating to its Too Faced, BECCA, Smashbox and GLAMGLOW reporting units. The Company concluded that the changes in circumstances in these reporting units triggered the need for an interim impairment review of their respective trademarks and goodwill. These changes in circumstances were also an indicator that the carrying amounts of their respective long-lived assets, including customer lists, may not be recoverable. Accordingly, the Company performed interim impairment tests for the trademarks and recoverability tests for the long-lived assets as of March 31, 2020. The Company concluded that the carrying amounts of the long-lived assets were recoverable. The Company also concluded that the carrying values of the trademarks exceeded their estimated fair values, which were determined utilizing the relief-from-royalty method to determine discounted projected future cash flows based on probability weighted cash flows, and recorded impairment charges. After adjusting the carrying value of the trademarks, the Company completed interim quantitative impairment tests for goodwill and recorded goodwill impairment charges for each of these reporting units. The fair value of each reporting unit was based upon an equal weighting of the income and market approaches, utilizing estimated cash flows, based on probability weighted undiscounted cash flows, and a terminal value, discounted at a rate of return that reflects the relative risk of the cash flows, as well as valuation multiples derived from comparable publicly traded companies that are applied to operating performance of the reporting unit. A summary of the impairment charges for the three and nine months ended March 31, 2020 and the remaining trademark and goodwill carrying values as of March 31, 2020, for each reporting unit, are as follows: Impairment Charge (In millions) Three Months Ended Nine Months Ended Carrying Value Reporting Unit: Product Category Region Trademark Goodwill Trademark Goodwill Trademark Goodwill Too Faced Makeup The Americas $ 42 $ 162 $ 253 $ 592 $ 272 $ 13 BECCA Makeup The Americas 14 35 47 70 51 28 Smashbox Makeup The Americas 1 26 23 72 32 — GLAMGLOW Skin care The Americas 1 52 1 52 62 62 Total $ 58 $ 275 $ 324 $ 786 $ 417 $ 103

CHARGES ASSOCIATED WITH RESTRUC

CHARGES ASSOCIATED WITH RESTRUCTURING AND OTHER ACTIVITIES	9 Months Ended
	Mar. 31, 2021
Restructuring and Related Activities [Abstract]
CHARGES ASSOCIATED WITH RESTRUCTURING AND OTHER ACTIVITIES	CHARGES ASSOCIATED WITH RESTRUCTURING AND OTHER ACTIVITIES Charges associated with restructuring activities for the three months ended March 31, 2021 were as follows: Sales Cost of Sales Operating Expenses Total (In millions) Restructuring Other Leading Beauty Forward Program $ — $ (1) $ 3 $ 4 $ 6 Post-COVID Business Acceleration Program 10 5 121 3 139 Total $ 10 $ 4 $ 124 $ 7 $ 145 Charges associated with restructuring activities for the nine months ended March 31, 2021 were as follows: Sales Cost of Sales Operating Expenses Total (In millions) Restructuring Other Leading Beauty Forward Program $ — $ 4 $ (7) $ 9 $ 6 Post-COVID Business Acceleration Program 10 5 167 3 185 Total $ 10 $ 9 $ 160 $ 12 $ 191 Charges associated with restructuring and other activities are not allocated to our product categories or geographic regions because they are centrally directed and controlled, are not included in internal measures of product category or geographic region performance and result from activities that are deemed Company-wide initiatives to redesign, resize and reorganize select areas of the business. Leading Beauty Forward Program In May 2016, the Company announced a multi-year initiative (“Leading Beauty Forward Program” or “LBF Program”) to build on its strengths and better leverage its cost structure to free resources for investment to continue its growth momentum. The LBF Program is designed to enhance the Company’s go-to-market capabilities, reinforce its leadership in global prestige beauty and continue creating sustainable value. As of June 30, 2019, the Company concluded the approvals of all major initiatives under the LBF Program related to the optimization of select corporate functions, supply chain activities, and corporate and regional market support structures, as well as the exit of underperforming businesses, and expects to substantially complete those initiatives through fiscal 2021. LBF Program Approvals The LBF Program approved restructuring and other charges expected to be incurred were: Sales Cost of Sales Operating Expenses Total (In millions) Restructuring Other Total Charges (Adjustments) Approved Cumulative through June 30, 2020 $ 13 $ 85 $ 511 $ 358 $ 967 Nine months ended March 31, 2021 1 — (11) 10 — Cumulative through March 31, 2021 $ 14 $ 85 $ 500 $ 368 $ 967 Included in the above table, cumulative LBF Program restructuring initiatives approved by the Company by major cost type were: (In millions) Employee- Asset- Contract Other Exit Total Restructuring Charges (Adjustments) Approved Cumulative through June 30, 2020 $ 460 $ 28 $ 7 $ 16 $ 511 Nine months ended March 31, 2021 (13) — 2 — (11) Cumulative through March 31, 2021 $ 447 $ 28 $ 9 $ 16 $ 500 The Company records approved charges associated with restructuring and other activities once the relevant accounting criteria have been met. LBF Program Restructuring and Other Charges Total cumulative charges recorded associated with restructuring and other activities for the LBF Program were: (In millions) Sales Cost of Sales Operating Expenses Total Restructuring Other Total Charges (Adjustments) Cumulative through June 30, 2020 $ 14 $ 65 $ 491 $ 304 $ 874 Nine months ended March 31, 2021 — 4 (7) 9 6 Cumulative through March 31, 2021 $ 14 $ 69 $ 484 $ 313 $ 880 (In millions) Employee- Asset- Contract Other Exit Total Restructuring Charges (Adjustments) Cumulative through June 30, 2020 $ 451 $ 27 $ 6 $ 7 $ 491 Nine months ended March 31, 2021 (10) — 1 2 (7) Cumulative through March 31, 2021 $ 441 $ 27 $ 7 $ 9 $ 484 Employee-related costs reflect adjustments to the accrual estimate for certain employees who either resigned or transferred to other existing positions within the Company. Changes in accrued restructuring charges for the nine months ended March 31, 2021 relating to the LBF Program were: (In millions) Employee- Asset- Contract Other Exit Total Balance at June 30, 2020 $ 112 $ — $ — $ — $ 112 Charges (adjustments) (10) — 1 2 (7) Cash payments (50) — (1) — (51) Translation adjustments 1 — — — 1 Balance at March 31, 2021 $ 53 $ — $ — $ 2 $ 55 Accrued restructuring charges at March 31, 2021 relating to the LBF Program are expected to result in cash expenditures funded from cash provided by operations of approximately $37 million, $14 million and $4 million for the remainder of fiscal 2021 and for fiscal 2022 and 2023, respectively. Additional information about the LBF Program is included in the notes to consolidated financial statements in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2020. Post-COVID Business Acceleration Program On August 20, 2020, the Company announced a two-year restructuring program, Post-COVID Business Acceleration Program (the “PCBA Program”), designed to resize the Company's business against the dramatic shifts to its distribution landscape and consumer behaviors in the wake of the COVID-19 pandemic. The PCBA Program is designed to help improve efficiency and effectiveness by rebalancing resources to growth areas of prestige beauty. It is expected to further strengthen the Company by building upon the foundational capabilities in which the Company has invested. The PCBA Program’s main areas of focus include accelerating the shift to online with the realignment of the Company’s distribution network reflecting freestanding store and certain department store closures, with a focus on North America and Europe, the Middle East & Africa; the reduction in brick-and-mortar point of sale employees and related support staff; and the redesign of the Company’s regional branded marketing organizations, plus select opportunities in global brands and functions. This program is expected to position the Company to better execute its long-term strategy while strengthening its financial flexibility. At this time the Company estimates a net reduction over the duration of the PCBA Program in the range of approximately 1,500 to 2,000 positions globally, including temporary and part-time employees. This reduction takes into account the elimination of some positions, retraining and redeployment of certain employees and investment in new positions in key areas. The Company also estimates the closure over the duration of the PCBA Program of approximately 10% to 15% of its freestanding stores globally, primarily in Europe, the Middle East & Africa and in North America. The Company plans to approve specific initiatives under the PCBA Program through fiscal 2022 and expects to complete those initiatives through fiscal 2023. The Company expects that the PCBA Program will result in related restructuring and other charges totaling between $400 million and $500 million, before taxes. PCBA Program Approvals The PCBA Program cumulative charges approved by the Company through March 31, 2021 were: Sales Cost of Sales Operating Expenses Total (In millions) Restructuring Other Total Charges (Adjustments) Approved Nine months ended March 31, 2021 $ 39 $ (6) $ 180 $ 17 $ 230 Included in the above table, cumulative PCBA Program restructuring initiatives approved by the Company through March 31, 2021 by major cost type were: (In millions) Employee- Asset- Contract Other Exit Total Restructuring Charges Approved Nine months ended March 31, 2021 $ 73 $ 99 $ 5 $ 3 $ 180 Specific actions taken since the PCBA Program inception include: • Optimize Distribution Network – To help restore profitability to pre-COVID-19 pandemic levels in certain areas of its distribution network and, as part of a broader initiative to be completed in phases, the Company has approved initiatives to close a number of underperforming freestanding stores, counters and other retail locations, mainly in certain affiliates in Europe, the Middle East & Africa and the United Kingdom, North America, Latin America and the Company's travel retail network. These anticipated closures reflect changing consumer behavior including higher demand for online and omnichannel capabilities. These activities will result in a net reduction in workforce, inventory and other asset write-offs, product returns, and termination of contracts. • Optimize Digital Organization and Other Go-To-Market Organizations – The Company approved initiatives to enhance its go-to-market capabilities and shift more resources to support online growth. These actions will result in a net reduction of the workforce, which includes position eliminations, the re-leveling of certain positions and an investment in new capabilities. • Optimize Select Marketing, Brand and Global Functions – The Company has started to reduce its corporate office footprint and is moving toward the future of work in a post-COVID environment, by restructuring where and how its employees work and collaborate. These actions will result primarily in lease termination fees. • Exit of the Global Distribution of BECCA Products – In reviewing the Company's brand portfolio to improve efficiency and to ensure the sustainability of long-term investments, the decision was made to exit the global distribution of BECCA products due to its limited distribution, the ongoing decline in product demand and the challenging environment caused by the COVID-19 pandemic. These activities resulted in charges for the impairment of goodwill and other intangible assets, product returns, termination of contracts, and employee severance. The Company expects to substantially complete these initiatives during fiscal 2022. PCBA Program Restructuring and Other Charges Restructuring charges are comprised of the following: Employee-Related Costs – Employee-related costs are primarily comprised of severance and other post-employment benefit costs, calculated based on salary levels, prior service and other statutory minimum benefits, if applicable. Asset-Related Costs – Asset-related costs primarily consist of asset write-offs or accelerated depreciation related to long-lived assets in certain freestanding stores (including rights associated with commercial operating leases and operating lease right-of-use assets) that will be taken out of service prior to their existing useful life as a direct result of a restructuring initiative. These costs also include goodwill and other intangible asset impairment charges relating to the exit of the global distribution of BECCA products. Contract Terminations – Costs related to contract terminations include continuing payments to a third party after the Company has ceased benefiting from the rights conveyed in the contract, or a payment made to terminate a contract prior to its expiration. Other Exit Costs – Other exit costs related to restructuring activities generally include costs to relocate facilities or employees, recruiting to fill positions as a result of relocation of operations, and employee outplacement for separated employees. Other charges associated with restructuring activities are comprised of the following: Sales Returns and Cost of Sales – Product returns (offset by the related cost of sales) and inventory write-offs or write-downs as a direct result of an approved restructuring initiative to exit certain businesses or locations will be recorded as a component of Net sales and/or Cost of sales when estimable and reasonably assured. Other Charges – The Company approved other charges related to the design and implementation of approved initiatives, which are charged to Operating expenses as incurred and primarily include the following: • Consulting and other professional services for organizational design of the future structures and processes as well as the implementation thereof, • Temporary labor backfill, • Costs to establish and maintain a Project Management Office (“PMO”) for the duration of the PCBA Program, including internal costs for employees dedicated solely to project management activities, and other PMO-related expenses incremental to the Company’s ongoing operations (e.g., rent and utilities), and • Recruitment and training costs for new and reskilled employees to acquire and apply the capabilities needed to perform responsibilities as a direct result of an approved restructuring initiative. The Company records approved charges associated with restructuring and other activities once the relevant accounting criteria have been met. Total cumulative charges recorded associated with restructuring and other activities for the PCBA Program were: Sales Cost of Sales Operating Expenses Total (In millions) Restructuring Other Total Charges Nine months ended March 31, 2021 $ 10 $ 5 $ 167 $ 3 $ 185 (In millions) Employee- Asset- Related Costs (1) Contract Other Exit Total Restructuring Charges Nine months ended March 31, 2021 $ 70 $ 93 $ 4 $ — $ 167 (1) Asset-related costs include goodwill and other intangible asset impairment charges of $13 million and $34 million, respectively, relating to the exit of the global distribution of BECCA products. Changes in accrued restructuring charges for the nine months ended March 31, 2021 relating to the PCBA Program were: (In millions) Employee- Asset- Contract Other Exit Total Charges $ 70 $ 93 $ 4 $ — $ 167 Cash payments (8) — (4) — (12) Noncash asset write-offs — (93) — — (93) Balance at March 31, 2021 $ 62 $ — $ — $ — $ 62 Accrued restructuring charges at March 31, 2021 relating to the PCBA Program are expected to result in cash expenditures funded from cash provided by operations of approximately $37 million, $18 million, and $7 million for the remainder of fiscal 2021 and for fiscal 2022 and 2023, respectively.

DEBT

DEBT	9 Months Ended
	Mar. 31, 2021
Debt Disclosure [Abstract]
DEBT	DEBT In August 2020, the Company repaid the remaining $750 million borrowed under its $1,500 million revolving credit facility that was outstanding as of June 30, 2020. In March 2021, the Company completed a public offering of $600 million aggregate principal amount of its 1.950% Senior Notes due March 15, 2031 (the “2031 Senior Notes”). The Company used some of the net proceeds from this offering for general corporate purposes, which included operating expenses, working capital and capital expenditures. In addition, the Company intends to use the net proceeds from this offering to repay the 1.700% Senior Notes due May 10, 2021 and fund a portion of the purchase price to increase the Company's investment in DECIEM Beauty Group Inc. These recently issued notes are summarized as follows: ($ in millions) Issue Date Price Yield Unamortized Debt Semi-annual 2031 Senior Notes (1) March 2021 99.340 % 2.023 % $ (4) $ (4) March 15/September 15 (1) In March 2020, in anticipation of the issuance of the 2031 Senior Notes, the Company entered into a series of treasury lock agreements on a notional amount totaling $200 million at a weighted-average all-in rate of 0.84%. The treasury lock agreements were settled upon the issuance of the new debt, and the Company recognized a gain in OCI of $11 million that is being amortized to interest expense over the life of the 2031 Senior Notes. As a result of the treasury lock agreements, as well as the debt discount and debt issuance costs, the effective interest rate on the 2031 Senior Notes will be 1.89% over the life of the debt. See Note 16 – Subsequent Events for further information relating to the debt repayment made subsequent to March 31, 2021.

DERIVATIVE FINANCIAL INSTRUMENT

DERIVATIVE FINANCIAL INSTRUMENTS	9 Months Ended
	Mar. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]
DERIVATIVE FINANCIAL INSTRUMENTS	DERIVATIVE FINANCIAL INSTRUMENTS The Company addresses certain financial exposures through a controlled program of risk management that includes the use of derivative financial instruments. The Company enters into foreign currency forward contracts, and may enter into option contracts, to reduce the effects of fluctuating foreign currency exchange rates. In addition, the Company enters into interest rate derivatives to manage the effects of interest rate movements on the Company’s aggregate liability portfolio, including potential future debt issuances. The Company enters into the net investment hedges to offset the risk of changes in the U.S. dollar value of the Company’s investment in these foreign operations due to fluctuating foreign exchange rates. Time value is excluded from the effectiveness assessment and is recognized under a systematic and rational method over the life of the hedging instrument in Selling, general and administrative expenses. The net gain or loss on net investment hedges is recorded within translation adjustments, as a component of accumulated OCI (“AOCI”) on the Company’s consolidated balance sheets, until the sale or substantially complete liquidation of the underlying assets of the Company’s investment. The Company also enters into foreign currency forward contracts, and may use option contracts, not designated as hedging instruments, to mitigate the change in fair value of specific assets and liabilities on the consolidated balance sheets. At March 31, 2021, the notional amount of derivatives not designated as hedging instruments was $4,404 million. The Company does not utilize derivative financial instruments for trading or speculative purposes. Costs associated with entering into derivative financial instruments have not been material to the Company’s consolidated financial results. For each derivative contract entered into, where the Company looks to obtain hedge accounting treatment, the Company formally and contemporaneously documents all relationships between hedging instruments and hedged items, as well as its risk-management objective and strategy for undertaking the hedge transaction, the nature of the risk being hedged, and how the hedging instruments’ effectiveness in offsetting the hedged risk will be assessed prospectively and retrospectively. This process includes linking all derivatives to specific assets and liabilities on the balance sheet or to specific firm commitments or forecasted transactions. At inception, the Company evaluates the effectiveness of hedge relationships quantitatively, and has elected to perform, after initial evaluation, qualitative effectiveness assessments of certain hedge relationships to support an ongoing expectation of high effectiveness, if effectiveness testing is required. If based on the qualitative assessment, it is determined that a derivative has ceased to be a highly effective hedge, the Company will perform a quantitative assessment to determine whether to discontinue hedge accounting with respect to that derivative prospectively. The fair values of the Company’s derivative financial instruments included in the consolidated balance sheets are presented as follows: Asset Derivatives Liability Derivatives Fair Value (1) Fair Value (1) (In millions) Balance Sheet March 31 June 30 Balance Sheet March 31 June 30 Derivatives Designated as Hedging Instruments Foreign currency cash flow hedges Prepaid expenses and other current assets $ 16 $ 26 Other accrued liabilities $ 21 $ 3 Net investment hedges Prepaid expenses and other current assets 115 21 Other accrued liabilities — 62 Interest rate-related derivatives Prepaid expenses and other current assets 7 15 Other accrued liabilities 15 3 Total Derivatives Designated as Hedging Instruments 138 62 36 68 Derivatives Not Designated as Hedging Instruments Foreign currency forward contracts Prepaid expenses and other current assets 5 40 Other accrued liabilities 108 15 Total derivatives $ 143 $ 102 $ 144 $ 83 (1) See Note 7 – Fair Value Measurements for further information about how the fair value of derivative assets and liabilities are determined. The amounts of the gains and losses related to the Company’s derivative financial instruments designated as hedging instruments that are included in the assessment of effectiveness are as follows: Amount of Gain (Loss) Location of Gain (Loss) Amount of Gain (Loss) Reclassified from AOCI into Earnings (Loss) (1) Three Months Ended Three Months Ended (In millions) 2021 2020 2021 2020 Derivatives in Cash Flow Hedging Relationships: Foreign currency forward contracts $ 22 $ 46 Net sales $ (7) $ 10 Interest rate-related derivatives 11 (2) Interest expense (1) — 33 44 (8) 10 Derivatives in Net Investment Hedging Relationships (2) : Foreign currency forward contracts (3) 125 (20) — — Total derivatives $ 158 $ 24 $ (8) $ 10 (1) The amount reclassified into earnings (loss) as a result of the discontinuance of cash flow hedges because probable forecasted transactions will no longer occur by the end of the original time period was not material. (2) During the three months ended March 31, 2021 and 2020, the gain recognized in earnings (loss) from net investment hedges related to the amount excluded from effectiveness testing was $5 million and $12 million, respectively. (3) Included within translation adjustments as a component of AOCI on the Company’s consolidated balance sheets. Amount of Gain (Loss) Location of Gain (Loss) Amount of Gain (Loss) Reclassified from AOCI into Earnings (1) Nine Months Ended Nine Months Ended (In millions) 2021 2020 2021 2020 Derivatives in Cash Flow Hedging Relationships: Foreign currency forward contracts $ (43) $ 50 Net sales $ (11) $ 29 Interest rate-related derivatives 14 (11) Interest expense (2) — (29) 39 (13) 29 Derivatives in Net Investment Hedging Relationships (2) : Foreign currency forward contracts (3) (17) (54) — — Total derivatives $ (46) $ (15) $ (13) $ 29 (1) The amount reclassified into earnings as a result of the discontinuance of cash flow hedges because probable forecasted transactions will no longer occur by the end of the original time period was not material. (2) During the nine months ended March 31, 2021 and 2020, the gain recognized in earnings from net investment hedges related to the amount excluded from effectiveness testing was $15 million and $37 million, respectively. (3) Included within translation adjustments as a component of AOCI on the Company’s consolidated balance sheets. Amount of Gain (Loss) Recognized in Earnings (Loss) on Derivatives (1) Location of Gain (Loss) Recognized in Earnings (Loss) on Derivatives Three Months Ended Nine Months Ended (In millions) 2021 2020 2021 2020 Derivatives in Fair Value Hedging Relationships: Interest rate swap contracts Interest expense $ (18) $ 12 $ (23) $ 13 (1) Changes in the fair value of the interest rate swap agreements are exactly offset by the change in the fair value of the underlying long-term debt. Additional information regarding the cumulative amount of fair value hedging gain (loss) recognized in earnings for items designated and qualifying as hedged items in fair value hedges is as follows: (In millions) Line Item in the Consolidated Balance Sheets in Carrying Amount of the Cumulative Amount of Fair March 31, 2021 March 31, 2021 Current debt $ 451 $ 1 Long-term debt 936 (9) Total debt $ 1,387 $ (8) Additional information regarding the effects of fair value and cash flow hedging relationships for derivatives designated and qualifying as hedging instruments is as follows: Three Months Ended March 31 2021 2020 (In millions) Net Sales Interest Net Sales Interest Total amounts of income and expense line items presented in the consolidated statements of earnings (loss) in which the effects of fair value and cash flow hedges are recorded $ 3,864 $ 43 $ 3,345 $ 42 The effects of fair value and cash flow hedging relationships: Gain (loss) on fair value hedge relationships – interest rate contracts: Hedged item Not applicable 18 Not applicable (12) Derivatives designated as hedging instruments Not applicable (18) Not applicable 12 Gain (loss) on cash flow hedge relationships – interest rate contracts: Amount of loss reclassified from AOCI into earnings (loss) Not applicable (1) Not applicable — Gain (loss) on cash flow hedge relationships – foreign currency forward contracts: Amount of gain reclassified from AOCI into earnings (loss) (7) Not applicable 10 Not applicable Nine Months Ended March 31 2021 2020 (In millions) Net Sales Interest Net Sales Interest Total amounts of income and expense line items presented in the consolidated statements of earnings in which the effects of fair value and cash flow hedges are recorded $ 12,279 $ 131 $ 11,864 $ 112 The effects of fair value and cash flow hedging relationships: Gain (loss) on fair value hedge relationships – interest rate contracts: Hedged item Not applicable 23 Not applicable (13) Derivatives designated as hedging instruments Not applicable (23) Not applicable 13 Gain (loss) on cash flow hedge relationships – interest rate contracts: Amount of loss reclassified from AOCI into earnings Not applicable (2) Not applicable — Gain (loss) on cash flow hedge relationships – foreign currency forward contracts: Amount of gain reclassified from AOCI into earnings (11) Not applicable 29 Not applicable The amount of gains and losses related to the Company’s derivative financial instruments not designated as hedging instruments are presented as follows: Amount of Gain (Loss) Location of Gain (Loss) Recognized in Earnings (Loss) on Derivatives Three Months Ended Nine Months Ended (In millions) 2021 2020 2021 2020 Derivatives Not Designated as Hedging Instruments: Foreign currency forward contracts Selling, general and administrative $ (97) $ 49 $ (34) $ 52 Cash Flow Hedges The Company enters into foreign currency forward contracts, and may enter into foreign currency option contracts, to hedge anticipated transactions and receivables and payables denominated in foreign currencies, for periods consistent with the Company’s identified exposures. The purpose of the hedging activities is to minimize the effect of foreign exchange rate movements on the cash flows that the Company receives from foreign subsidiaries. The foreign currency forward contracts entered into to hedge anticipated transactions have been designated as cash flow hedges and have varying maturities through the end of December 2022. Hedge effectiveness of the foreign currency forward contracts is based on the forward method, which includes time value in the effectiveness assessment. At March 31, 2021, the Company had cash flow hedges outstanding with a notional amount totaling $1,390 million. The Company may enter into interest rate forward contracts to hedge anticipated issuance of debt for periods consistent with the Company’s identified exposures. The purpose of the hedging activities is to minimize the effect of interest rate movements on the cost of debt issuance. For hedge contracts that are no longer deemed highly effective, hedge accounting is discontinued, and gains and losses in AOCI are reclassified to sales when the underlying forecasted transaction occurs. If it is probable that the forecasted transaction will no longer occur, then any gains or losses in AOCI are reclassified to current-period sales. As of March 31, 2021, the Company’s foreign currency cash flow hedges were highly effective. The estimated net loss on the Company’s derivative instruments designated as cash flow hedges as of March 31, 2021 that is expected to be reclassified from AOCI into earnings, net of tax, within the next twelve months is $8 million. The accumulated net gain on derivative instruments in AOCI was $4 million and $20 million as of March 31, 2021 and June 30, 2020, respectively. Fair Value Hedges The Company enters into interest rate derivative contracts to manage the exposure to interest rate fluctuations on its funded indebtedness. The Company has interest rate swap agreements, with notional amounts totaling $450 million, $250 million and $700 million to effectively convert the fixed rate interest on its 2021 Senior Notes, 2022 Senior Notes and 2030 Senior Notes, respectively, to variable interest rates based on three-month LIBOR plus a margin. These interest rate swap agreements are designated as fair value hedges of the related long-term debt, and the changes in the fair value of the interest rate swap agreements are exactly offset by the change in the fair value of the underlying long-term debt. See Note 16 – Subsequent Events for further information relating to the interest rate swap transactions that occurred subsequent to March 31, 2021. Net Investment Hedges The Company enters into foreign currency forward contracts, designated as net investment hedges, to hedge a portion of its net investment in certain foreign operations. The net gain or loss on these contracts is recorded within translation adjustments, as a component of AOCI on the Company’s consolidated balance sheets. The purpose of the hedging activities is to minimize the effect of foreign exchange rate movements on the Company’s net investment in these foreign operations. The net investment hedge contracts have varying maturities through the end of April 2021. Hedge effectiveness of the net investment hedge contracts is based on the spot method. At March 31, 2021, the Company had net investment hedges outstanding with a notional amount totaling $1,920 million. Credit Risk As a matter of policy, the Company enters into derivative contracts only with counterparties that have a long-term credit rating of at least A- or higher by at least two nationally recognized rating agencies. The counterparties to these contracts are major financial institutions. Exposure to credit risk in the event of nonperformance by any of the counterparties is limited to the gross fair value of contracts in asset positions, which totaled $143 million at March 31, 2021. To manage this risk, the Company has strict counterparty credit guidelines that are continually monitored. Accordingly, management believes risk of loss under these hedging contracts is remote.

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	9 Months Ended
	Mar. 31, 2021
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENTS	FAIR VALUE MEASUREMENTS The Company records certain of its financial assets and liabilities at fair value, which is defined as the price that would be received to sell an asset or paid to transfer a liability, in the principal or most advantageous market for the asset or liability, in an orderly transaction between market participants at the measurement date. The accounting for fair value measurements must be applied to nonfinancial assets and nonfinancial liabilities that require initial measurement or remeasurement at fair value, which principally consist of assets and liabilities acquired through business combinations and goodwill, indefinite-lived intangible assets and long-lived assets for the purposes of calculating potential impairment. The Company is required to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The three levels of inputs that may be used to measure fair value are as follows: Level 1: Inputs based on quoted market prices for identical assets or liabilities in active markets at the measurement date. Level 2: Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data. Level 3: Inputs reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. The inputs are unobservable in the market and significant to the instrument’s valuation. The following table presents the Company’s hierarchy for its financial assets and liabilities measured at fair value on a recurring basis as of March 31, 2021: (In millions) Level 1 Level 2 Level 3 Total Assets: Money market funds $ 3,518 $ — $ — $ 3,518 Foreign currency forward contracts — 136 — 136 Interest rate-related derivatives — 7 — 7 Total $ 3,518 $ 143 $ — $ 3,661 Liabilities: Foreign currency forward contracts $ — $ 129 $ — $ 129 Interest rate-related derivatives — 15 — 15 Contingent consideration — — 2 2 Total $ — $ 144 $ 2 $ 146 The following table presents the Company’s hierarchy for its financial assets and liabilities measured at fair value on a recurring basis as of June 30, 2020: (In millions) Level 1 Level 2 Level 3 Total Assets: Money market funds $ 2,810 $ — $ — $ 2,810 Foreign currency forward contracts — 87 — 87 Interest rate-related derivatives — 15 — 15 Total $ 2,810 $ 102 $ — $ 2,912 Liabilities: Foreign currency forward contracts $ — $ 80 $ — $ 80 Interest rate-related derivatives — 3 — 3 Contingent consideration — — 4 4 Total $ — $ 83 $ 4 $ 87 The estimated fair values of the Company’s financial instruments are as follows: March 31 June 30 (In millions) Carrying Fair Carrying Fair Nonderivatives Cash and cash equivalents $ 6,399 $ 6,399 $ 5,022 $ 5,022 Current and long-term debt 5,958 6,465 6,136 6,902 Contingent consideration 2 2 4 4 Derivatives Foreign currency forward contracts – asset (liability), net 7 7 7 7 Interest rate-related derivatives – asset (liability), net (8) (8) 12 12 The following table presents the Company’s impairment charges for the nine months ended March 31, 2021 for certain of its nonfinancial assets measured at fair value on a nonrecurring basis, classified as Level 3, due to a change in circumstances that triggered an interim impairment test: (In millions) Impairment charges Date of Fair Value Measurement Fair Value (1) Goodwill GLAMGLOW $ 54 November 30, 2020 $ — BECCA (2) 13 February 28, 2021 — Total 67 — Other intangible assets, net (trademark and customer lists) GLAMGLOW 27 November 30, 2020 36 BECCA (2) 34 February 28, 2021 — Total 61 36 Long-lived assets 33 March 31, 2021 35 Total $ 161 $ 71 (1) See Note 3 - Goodwill and Other Intangible Assets for discussion of the valuation techniques used to measure fair value, the description of the inputs and information used to develop those inputs. (2) See Note 4 – Charges Associated with Restructuring and Other Activities for further information relating to goodwill and other intangible asset impairment charges recorded in connection with the exit of the global distribution of BECCA products. The following table presents the Company’s impairment charges for the nine months ended March 31, 2020 for certain of its nonfinancial assets measured at fair value on a nonrecurring basis, classified as Level 3, due to a change in circumstances that triggered an interim impairment test: (In millions) Impairment charges Date of Fair Value Measurement Fair Value (1) Goodwill $ 786 March 31, 2020 $ 103 Other intangible assets, net (trademark) 324 March 31, 2020 417 Long-lived assets 13 March 31, 2020 11 Total $ 1,123 $ 531 (1) See Note 3 - Goodwill and Other Intangible Assets for discussion of the valuation techniques used to measure fair value, the description of the inputs and information used to develop those inputs. The following methods and assumptions were used to estimate the fair value of the Company’s financial instruments for which it is practicable to estimate that value: Cash and cash equivalents – Cash and all highly-liquid securities with original maturities of three months or less are classified as cash and cash equivalents, primarily consisting of cash deposits in interest bearing accounts, time deposits and money market funds (classified within Level 1 of the valuation hierarchy). Cash deposits in interest bearing accounts and time deposits are carried at cost, which approximates fair value due to the short maturity of cash equivalent instruments. Foreign currency forward contracts – The fair values of the Company’s foreign currency forward contracts were determined using an industry-standard valuation model, which is based on an income approach. The significant observable inputs to the model, such as swap yield curves and currency spot and forward rates, were obtained from an independent pricing service. To determine the fair value of contracts under the model, the difference between the contract price and the current forward rate was discounted using LIBOR for contracts with maturities up to 12 months, and swap yield curves for contracts with maturities greater than 12 months. Interest rate contracts – The fair values of the Company’s interest rate contracts were determined using an industry-standard valuation model, which is based on the income approach. The significant observable inputs to the model, such as treasury yield curves, swap yield curves and LIBOR forward rates, were obtained from independent pricing services. Current and long-term debt – The fair value of the Company’s debt was estimated based on the current rates offered to the Company for debt with the same remaining maturities. To a lesser extent, debt also includes finance lease obligations for which the carrying amount approximates the fair value. The Company’s debt is classified within Level 2 of the valuation hierarchy. Contingent consideration – Contingent consideration obligations consist of potential obligations related to the Company’s acquisitions in previous years. The amounts to be paid under these obligations are contingent upon the achievement of stipulated financial targets by the business subsequent to acquisition. At March 31, 2021, the fair values of the contingent consideration related to certain acquisition earn-outs were based on the Company’s estimate of the applicable financial targets as per the terms of the agreements. Significant changes in the projected future operating results would result in a significantly higher or lower fair value measurement. As these are unobservable inputs, the Company’s contingent consideration is classified within Level 3 of the valuation hierarchy. Changes in the fair value of the contingent consideration obligations for nine months ended March 31, 2021 are included in Selling, general and administrative expenses in the accompanying consolidated statements of earnings (loss) and were as follows: (In millions) Fair Value Contingent consideration at June 30, 2020 $ 4 Changes in fair value (2) Contingent consideration at March 31, 2021 $ 2

REVENUE RECOGNITION

REVENUE RECOGNITION	9 Months Ended
	Mar. 31, 2021
Revenue from Contract with Customer [Abstract]
REVENUE RECOGNITION	REVENUE RECOGNITION The Company’s revenue recognition accounting policies are described in the notes to consolidated financial statements in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2020. Accounts Receivable Accounts receivable, net is stated net of the allowance for doubtful accounts and customer deductions totaling $50 million and $63 million as of March 31, 2021 and June 30, 2020, respectively. During the first quarter of fiscal 2021, the Company adopted ASC 326 using the modified retrospective transition approach and, accordingly, the prior comparative period was not restated. Under this new standard, the Company is required to measure credit losses based on the Company’s estimate of expected losses rather than incurred losses, which generally results in earlier recognition of allowances for credit losses. In accordance with ASC 326, the Company evaluated certain criteria, including aging and historical write-offs, current economic condition of specific customers and future economic conditions of countries utilizing a consumption index to determine the appropriate allowance for credit losses. The Company writes-off receivables once it is determined that the receivables are no longer collectible and as allowed by local laws. Payment terms are short-term in nature and are generally less than one year. Changes in the allowance for credit losses are as follows: (In millions) Balance at June 30, 2020 $ 36 ASC 326 cumulative effect adjustment (pre-tax) 4 Adjustment for expected credit losses (5) Write-offs, net & other (10) Balance at March 31, 2021 $ 25 As a result of the adoption of ASC 326, the Company recorded a cumulative adjustment of approximately $3 million, net of tax, as a reduction to its fiscal 2021 opening balance of retained earnings relating to its trade receivables. The remaining balance of the allowance for doubtful accounts of $25 million, as of March 31, 2021, relates to non-credit losses, which are primarily due to customer deductions. Deferred Revenue Changes in deferred revenue during the period are as follows: Three Months Ended Nine Months Ended (In millions) 2021 2020 2021 2020 Deferred revenue, beginning of period $ 420 $ 425 $ 279 $ 361 Revenue recognized that was included in the deferred revenue balance at the beginning of the period (25) (26) (198) (268) Revenue deferred (released) during the period (30) (37) 278 269 Other (4) — 2 — Deferred revenue, end of period $ 361 $ 362 $ 361 $ 362 Transaction Price Allocated to the Remaining Performance Obligations At March 31, 2021, the combined estimated revenue expected to be recognized in the next twelve months related to performance obligations for customer loyalty programs, gift with purchase promotions, purchase with purchase promotions and gift card liabilities that are unsatisfied (or partially unsatisfied) is $310 million, and the remaining balance will be recognized beyond the next twelve months.

PENSION AND POST-RETIREMENT BEN

PENSION AND POST-RETIREMENT BENEFIT PLANS	9 Months Ended
	Mar. 31, 2021
Retirement Benefits [Abstract]
PENSION AND POST-RETIREMENT BENEFIT PLANS	PENSION AND POST-RETIREMENT BENEFIT PLANS The Company maintains pension plans covering substantially all of its full-time employees for its U.S. operations and a majority of its international operations. The Company also maintains post-retirement benefit plans that provide certain medical and dental benefits to eligible employees. Descriptions of these plans are included in the notes to consolidated financial statements in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2020. The components of net periodic benefit cost for the three months ended March 31, 2021 and 2020 consisted of the following: Pension Plans Other than U.S. International Post-retirement (In millions) 2021 2020 2021 2020 2021 2020 Service cost $ 12 $ 9 $ 9 $ 9 $ 2 $ — Interest cost 8 9 2 3 1 2 Expected return on plan assets (14) (14) (4) (4) (1) — Amortization of: Actuarial loss 5 5 1 1 — — Settlements — — 1 — — — Special termination benefits — — 1 1 — — Net periodic benefit cost $ 11 $ 9 $ 10 $ 10 $ 2 $ 2 The components of net periodic benefit cost for the nine months ended March 31, 2021 and 2020 consisted of the following: Pension Plans Other than U.S. International Post-retirement (In millions) 2021 2020 2021 2020 2021 2020 Service cost $ 34 $ 29 $ 27 $ 27 $ 2 $ 2 Interest cost 23 26 7 8 4 5 Expected return on plan assets (40) (40) (10) (11) (1) (1) Amortization of: Actuarial loss 15 12 3 4 — — Settlements — — 1 — — — Special termination benefits — — 10 1 — — Net periodic benefit cost $ 32 $ 27 $ 38 $ 29 $ 5 $ 6 During the nine months ended March 31, 2021, the Company made contributions to its international pension plans totaling $22 million. The amounts recognized in the consolidated balance sheets related to the Company’s pension and post-retirement benefit plans consist of the following: (In millions) March 31 June 30 Other assets $ 137 $ 127 Other accrued liabilities (27) (27) Other noncurrent liabilities (470) (440) Funded status (360) (340) Accumulated other comprehensive loss 304 324 Net amount recognized $ (56) $ (16)

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	9 Months Ended
	Mar. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	COMMITMENTS AND CONTINGENCIES Commitments In February 2021, the Company agreed to acquire additional shares in DECIEM Beauty Group Inc. (“DECIEM”) that will increase its existing equity interest from approximately 29% to approximately 76%. Upon closing, which is expected to occur in May 2021, the Company will pay approximately $1,000 million and will have the right to purchase, and will grant the remaining investors a right to sell to the Company, the remaining interests after a three-year period, with a purchase price based on the future performance of DECIEM. Legal Proceedings The Company is involved, from time to time, in litigation and other legal proceedings incidental to its business, including employment, intellectual property, real estate, environmental, regulatory, advertising, trade relations, tax, privacy, and product liability matters (including asbestos-related claims). Management believes that the outcome of current litigation and legal proceedings will not have a material adverse effect upon the Company’s business, results of operations, financial condition or cash flows. However, management’s assessment of the Company’s current litigation and other legal proceedings could change in light of the discovery of facts with respect to legal actions or other proceedings pending against the Company not presently known to the Company or determinations by judges, juries or other finders of fact which are not in accord with management’s evaluation of the possible liability or outcome of such litigation or proceedings. Reasonably possible losses in addition to the amounts accrued for such litigation and legal proceedings are not material to the Company’s consolidated financial statements.

STOCK PROGRAMS

STOCK PROGRAMS	9 Months Ended
	Mar. 31, 2021
Share-based Payment Arrangement [Abstract]
STOCK PROGRAMS	STOCK PROGRAMS Total net stock-based compensation expense is attributable to the granting of, and the remaining requisite service periods of stock options, restricted stock units (“RSUs”), performance share units (“PSUs”), long-term PSUs, long-term price-vested units (“PVUs”) and share units. Compensation expense attributable to net stock-based compensation was $86 million and $71 million for the three months ended March 31, 2021 and 2020, respectively, and was $255 million and $210 million for the nine months ended March 31, 2021 and 2020, respectively. Stock Options During the nine months ended March 31, 2021, the Company granted stock options in respect of approximately 1.5 million shares of Class A Common Stock with an exercise price per share of $218.40 and a weighted-average grant date fair value per share of $54.61. The fair value of each option grant was estimated on the date of grant using the Black-Scholes option-pricing model. The aggregate intrinsic value of stock options exercised during the nine months ended March 31, 2021 was $317 million. Restricted Stock Units The Company granted RSUs in respect of approximately 1.0 million shares of Class A Common Stock during the nine months ended March 31, 2021 with a weighted-average grant date fair value per share of $219.01 that, at the time of grant, are scheduled to vest as follows: 0.3 million in fiscal 2022, 0.4 million in fiscal 2023 and 0.3 million in fiscal 2024. Vesting of RSUs is generally subject to the continued employment or the retirement of the grantees. The RSUs are accompanied by dividend equivalent rights, payable upon settlement of the RSUs either in cash or shares (based on the terms of the particular award) and, as such, were valued at the closing market price of the Company’s Class A Common Stock on the date of grant. Performance Share Units During the nine months ended March 31, 2021, the Company granted PSUs with a target payout of approximately 0.1 million shares of Class A Common Stock with a weighted-average grant date fair value per share of $218.11, which will be settled in stock subject to the achievement of the Company’s net sales and diluted net earnings per common share for the three fiscal years ending June 30, 2023, all subject to continued employment or the retirement of the grantees. For PSUs granted, no settlement will occur for results below the applicable minimum threshold. PSUs are accompanied by dividend equivalent rights that will be payable in cash upon settlement of the PSUs and, as such, were valued at the closing market value of the Company’s Class A Common Stock on the date of grant. In September 2020, approximately 0.2 million shares of the Company’s Class A Common Stock were issued, and related accrued dividends were paid, relative to the target goals set at the time of the issuance, in settlement of 0.5 million PSUs which vested as of June 30, 2020. Long-term Performance Share Units In March 2021, the Company granted to the Company’s Chief Executive Officer (“CEO”) PSUs with an aggregate payout of 68,578 shares of the Company's Class A Common Stock, to incentivize him to continue serving through at least June 30, 2024. Generally, no portion of this award will vest unless the Company has achieved positive Cumulative Operating Income, as defined in the performance share unit award agreement, during the relevant performance period, and delivery of shares of the Company’s Class A Common Stock, if any, will be made on September 2, 2025. The PSUs are accompanied by dividend equivalent rights that will be payable in cash at the same time as any delivery of shares of the Company's Class A Common Stock. The aggregate grant date fair value of the PSUs of approximately $20 million was estimated using the closing stock price of the Company's Class A Common Stock on the date of grant. As of March 31, 2021, the total unrecognized compensation cost related to unvested PSU awards was $20 million and the related period over which it is expected to be recognized is approximately 3.3 years, subject to the performance condition being met. Long-term Price-Vested Units In March 2021, the Company granted to the Company’s CEO PVUs with an aggregate payout of 85,927 shares, divided into three tranches, of the Company's Class A Common Stock, to incentivize him to continue serving through at least June 30, 2024. Generally, no portion of this award will vest unless the Company has achieved positive Cumulative Operating Income, as defined in the price-vested unit award agreement, during the relevant performance period. In addition, the vesting of each tranche is contingent upon the Company’s achievement of the respective stock price goal, which means that the average closing price per share of the Company’s Class A Common Stock traded on the New York Stock Exchange be at or above the applicable stock price goal (noted in the table below) for 20 consecutive trading days during the applicable performance period. The number of shares subject to each tranche of the price-vested unit award, as well as the stock price goals, service periods, performance periods and share delivery dates for each tranche are as follows: Number Stock Price Goal Service Period Performance Period for Stock Price Goal Performance Period for Cumulative Operating Income Goal Share Delivery Date First tranche 27,457 $ 323.03 March 11, 2021 - June 30, 2024 March 11, 2021 - June 30, 2024 July 1, 2021 - June 30, 2025 September 2, 2025 Second tranche 28,598 $ 333.21 March 11, 2021 - June 30, 2024 March 11, 2021 - June 30, 2024 July 1, 2021 - June 30, 2025 September 2, 2025 Third tranche 29,872 $ 343.61 March 11, 2021 - June 30, 2024 March 11, 2021 - June 30, 2024 July 1, 2021 - June 30, 2025 September 2, 2025 Total shares 85,927 Generally, delivery of shares of the Company’s Class A Common Stock, if any, will be made on September 2, 2025. The PVUs are accompanied by dividend equivalent rights that will be payable in cash at the same time as any delivery of shares of the Company's Class A Common Stock. The aggregate grant date fair value of the PVUs of approximately $20 million was estimated using the Monte Carlo Method, which requires certain assumptions. The assumptions used for this award were as follows: Expected volatility 31.8 % Dividend yield 0.8 % Risk-free interest rate 0.4 % Expected term 3.3 years As of March 31, 2021, the total unrecognized compensation cost related to unvested PVU awards was $20 million and the related period over which it is expected to be recognized is approximately 3.3 years, subject to the performance conditions and stock price goals being met.

NET EARNINGS (LOSS) ATTRIBUTABL

NET EARNINGS (LOSS) ATTRIBUTABLE TO THE ESTEE LAUDER COMPANIES INC. PER COMMON SHARE	9 Months Ended
	Mar. 31, 2021
Earnings Per Share [Abstract]
NET EARNINGS (LOSS) ATTRIBUTABLE TO THE ESTEE LAUDER COMPANIES INC. PER COMMON SHARE	NET EARNINGS (LOSS) ATTRIBUTABLE TO THE ESTÉE LAUDER COMPANIES INC. PER COMMON SHARENet earnings (loss) attributable to The Estée Lauder Companies Inc. per common share (“basic EPS”) is computed by dividing net earnings (loss) attributable to The Estée Lauder Companies Inc. by the weighted-average number of common shares outstanding and shares underlying PSUs and RSUs where the vesting conditions have been met. Net earnings (loss) attributable to The Estée Lauder Companies Inc. per common share assuming dilution (“diluted EPS”) is computed by reflecting potential dilution from stock-based awards. A reconciliation between the numerator and denominator of the basic and diluted EPS computations is as follows: Three Months Ended Nine Months Ended (In millions, except per share data) 2021 2020 2021 2020 Numerator: Net earnings (loss) attributable to The Estée Lauder Companies Inc. $ 456 $ (6) $ 1,852 $ 1,146 Denominator: Weighted-average common shares outstanding – Basic 363.6 360.2 362.9 360.6 Effect of dilutive stock options (1) 4.1 — 3.9 4.6 Effect of PSUs (1) 0.2 — 0.2 0.3 Effect of RSUs (1) 1.1 — 1.1 1.6 Weighted-average common shares outstanding – Diluted 369.0 360.2 368.1 367.1 Net earnings (loss) attributable to The Estée Lauder Companies Inc. per common share: Basic $ 1.25 $ (.02) $ 5.10 $ 3.18 Diluted $ 1.24 $ (.02) $ 5.03 $ 3.12 (1) For the three months ended March 31, 2020, the effects of potentially dilutive stock options, PSUs and RSUs were excluded from the computation of diluted EPS as they were anti-dilutive due to the net loss incurred during the period. The shares of Class A Common Stock underlying stock options, RSUs and PSUs that were excluded in the computation of diluted EPS because their inclusion would be anti-dilutive were as follows: Three Months Ended Nine Months Ended (In millions) 2021 2020 2021 2020 Stock options (1) — — 0.9 1.3 RSUs and PSUs (1) — — 0.1 — (1) Not applicable for the three months ended March 31, 2020, since the effects of potentially dilutive stock options, PSUs and RSUs were excluded from the computation of diluted EPS as they were anti-dilutive due to the net loss incurred during the period. As of March 31, 2021 and 2020, 0.9 million and 1.2 million shares, respectively, of Class A Common Stock underlying PSUs have been excluded from the calculation of diluted EPS because the number of shares ultimately issued is contingent on the achievement of certain performance targets of the Company, as discussed in Note 11 – Stock Programs

EQUITY

EQUITY	9 Months Ended
	Mar. 31, 2021
Equity [Abstract]
EQUITY	EQUITY Total Stockholders’ Equity – The Estée Lauder Companies Inc. Three Months Ended Nine Months Ended (In millions) 2021 2020 2021 2020 Common stock, beginning of the period $ 6 $ 6 $ 6 $ 6 Stock-based compensation — — — — Common stock, end of the period 6 6 6 6 Paid-in capital, beginning of the period 5,068 4,615 4,790 4,403 Common stock dividends 1 1 2 3 Stock-based compensation 162 144 439 354 Paid-in capital, end of the period 5,231 4,760 5,231 4,760 Retained earnings, beginning of the period 11,159 10,775 10,134 9,984 Common stock dividends (195) (174) (563) (506) Net earnings (loss) attributable to The Estée Lauder Companies Inc. 456 (6) 1,852 1,146 Cumulative effect of adoption of new accounting standards — — (3) (29) Retained earnings, end of the period 11,420 10,595 11,420 10,595 Accumulated other comprehensive loss, beginning of the period (383) (569) (665) (563) Other comprehensive income (loss) (104) (143) 178 (149) Accumulated other comprehensive loss, end of the period (487) (712) (487) (712) Treasury stock, beginning of the period (10,429) (10,253) (10,330) (9,444) Acquisition of treasury stock (212) (65) (212) (768) Stock-based compensation (1) (2) (100) (108) Treasury stock, end of the period (10,642) (10,320) (10,642) (10,320) Total stockholders’ equity – The Estée Lauder Companies Inc. 5,528 4,329 5,528 4,329 Noncontrolling interests, beginning of the period 35 27 27 25 Net earnings attributable to noncontrolling interests 2 2 8 9 Distribution to noncontrolling interest holders (6) — (6) (4) Other comprehensive (income) loss (1) — 1 (1) Noncontrolling interests, end of the period 30 29 30 29 Total equity $ 5,558 $ 4,358 $ 5,558 $ 4,358 Cash dividends declared per common share $ .53 $ .48 $ 1.54 $ 1.39 The following is a summary of quarterly cash dividends declared per share on the Company’s Class A and Class B Common Stock during the nine months ended March 31, 2021: Date Declared Record Date Payable Date Amount per Share August 19, 2020 August 31, 2020 September 15, 2020 $ .48 October 30, 2020 November 30, 2020 December 15, 2020 $ .53 February 4, 2021 February 26, 2021 March 15, 2021 $ .53 On April 30, 2021, a dividend was declared in the amount of $.53 per share on the Company’s Class A and Class B Common Stock. The dividend is payable in cash on June 15, 2021 to stockholders of record at the close of business on May 28, 2021. Common Stock During the nine months ended March 31, 2021, the Company purchased approximately 1.2 million shares of its Class A Common Stock for $316 million. In March 2021, the Company resumed its repurchase of shares of the Company's Class A Common Stock. During the nine months ended March 31, 2021, approximately 4.6 million shares of the Company’s Class B Common Stock were converted into the same amount of shares of the Company’s Class A Common Stock. Accumulated Other Comprehensive Income The following table represents changes in AOCI, net of tax, by component for the nine months ended March 31, 2021: (In millions) Net Cash Retirement Plan and Other Retiree Benefit Adjustments Translation Total Balance at June 30, 2020 $ 14 $ (244) $ (435) $ (665) OCI before reclassifications (22) 1 (1) 175 (2) 154 Amounts reclassified to Net earnings 10 14 — 24 Net current-period OCI (12) 15 175 178 Balance at March 31, 2021 $ 2 $ (229) $ (260) $ (487) (1) Consists of foreign currency translation gains. (2) See Note 6 – Derivative Financial Instruments for gains (losses) relating to net investment hedges. The following table represents the effects of reclassification adjustments from AOCI into net earnings (loss) for the three and nine months ended March 31, 2021 and 2020: Amount Reclassified from AOCI Affected Line Item in Three Months Ended Nine Months Ended (In millions) 2021 2020 2021 2020 Gain (Loss) on Cash Flow Hedges Foreign currency forward contracts $ (7) $ 10 $ (11) $ 29 Net sales Interest rate-related derivatives (1) — (2) — Interest expense (8) 10 (13) 29 Benefit (provision) for deferred taxes 2 (2) 3 (7) Provision for income taxes $ (6) $ 8 (10) $ 22 Net earnings (loss) Retirement Plan and Other Retiree Benefit Adjustments Amortization of actuarial loss $ (6) $ (6) $ (18) $ (16) Other components of net periodic benefit cost (1) Settlements (1) — (1) — Other components of net periodic benefit cost (1) (7) (6) (19) (16) Earnings before income taxes (1) Benefit for deferred taxes 3 1 5 3 Provision for income taxes $ (4) $ (5) $ (14) $ (13) Net earnings (loss) Cumulative Translation Adjustments Gain on previously held equity method investment $ — $ — $ — $ 4 Other income Loss on liquidation of an investment in a foreign subsidiary — — — (6) Restructuring and other charges $ — $ — — $ (2) Net earnings (loss) Total reclassification adjustments, net $ (10) $ 3 $ (24) $ 7 Net earnings (loss) (1) See Note 9 – Pension and Post-Retirement Benefit Plans for additional information.

STATEMENT OF CASH FLOWS

STATEMENT OF CASH FLOWS	9 Months Ended
	Mar. 31, 2021
Supplemental Cash Flow Elements [Abstract]
STATEMENT OF CASH FLOWS	STATEMENT OF CASH FLOWS Supplemental cash flow information for the nine months ended March 31, 2021 and 2020 is as follows: (In millions) 2021 2020 Cash: Cash paid during the period for interest $ 108 $ 94 Cash paid during the period for income taxes $ 435 $ 472 Non-cash investing and financing activities: Property, plant and equipment accrued but unpaid $ 68 $ 47 Right-of-use assets obtained in exchange for new operating lease liabilities $ 167 $ 216

SEGMENT DATA AND RELATED INFORM

SEGMENT DATA AND RELATED INFORMATION	9 Months Ended
	Mar. 31, 2021
Segment Reporting [Abstract]
SEGMENT DATA AND RELATED INFORMATION	SEGMENT DATA AND RELATED INFORMATION Reportable operating segments include components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker (the “Chief Executive”) in deciding how to allocate resources and in assessing performance. Although the Company operates in one business segment, beauty products, management also evaluates performance on a product category basis. Product category performance is measured based upon net sales before returns associated with restructuring and other activities, and earnings before income taxes, other components of net periodic benefit cost, interest expense, interest income and investment income, net, other income, net, and charges associated with restructuring and other activities. Returns and charges associated with restructuring and other activities are not allocated to our product categories or geographic regions because they are centrally directed and controlled, are not included in internal measures of product category or geographic region performance and result from activities that are deemed Company-wide initiatives to redesign, resize and reorganize select areas of the business. The accounting policies for the Company’s reportable segments are substantially the same as those for the consolidated financial statements, as described in the notes to consolidated financial statements in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2020. The assets and liabilities of the Company are managed centrally and are reported internally in the same manner as the consolidated financial statements; thus, no additional information is produced for the Chief Executive or included herein. There has been no significant variance in the total or long-lived asset values associated with the Company’s segment data since June 30, 2020. Three Months Ended Nine Months Ended (In millions) 2021 2020 2021 2020 PRODUCT CATEGORY DATA Net sales: Skin Care $ 2,259 $ 1,723 $ 7,113 $ 5,770 Makeup 1,018 1,146 3,243 4,249 Fragrance 454 349 1,478 1,392 Hair Care 128 119 418 417 Other 15 8 37 36 3,874 3,345 12,289 11,864 Returns associated with restructuring and other activities (10) — (10) — Net sales $ 3,864 $ 3,345 $ 12,279 $ 11,864 Operating income (loss) before charges associated with restructuring and other activities: Skin Care $ 804 $ 418 $ 2,453 $ 1,822 Makeup (72) (283) (115) (790) Fragrance 47 — 248 163 Hair Care (17) (2) (10) 10 Other (1) 1 (1) 7 761 134 2,575 1,212 Reconciliation: Charges associated with restructuring and other activities (145) (25) (191) (63) Interest expense (43) (42) (131) (112) Interest income and investment income, net 9 14 40 41 Other components of net periodic benefit cost (2) (1) (12) (3) Other income — — — 576 Earnings before income taxes $ 580 $ 80 $ 2,281 $ 1,651 GEOGRAPHIC DATA (1) Net sales: The Americas $ 916 $ 892 $ 2,837 $ 3,278 Europe, the Middle East & Africa 1,706 1,525 5,276 5,281 Asia/Pacific 1,252 928 4,176 3,305 3,874 3,345 12,289 11,864 Returns associated with restructuring and other activities (10) — (10) — Net sales $ 3,864 $ 3,345 $ 12,279 $ 11,864 Operating income (loss): The Americas $ 155 $ (217) $ 256 $ (571) Europe, the Middle East & Africa 361 202 1,429 1,084 Asia/Pacific 245 149 890 699 761 134 2,575 1,212 Charges associated with restructuring and other activities (145) (25) (191) (63) Operating income $ 616 $ 109 $ 2,384 $ 1,149

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	9 Months Ended
	Mar. 31, 2021
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	SUBSEQUENT EVENTS Debt In April 2021, the Company repaid $450 million aggregate principal amount of its 1.70% Senior Notes due May 10, 2021 in full, partially from proceeds from the 2031 Senior Notes issued in March 2021 and cash on hand, and the corresponding interest rate swaps were settled. Derivative Financial Instruments In April 2021, the Company entered into an interest rate swap agreement with a notional amount of $300 million to partially convert the fixed rate interest on its outstanding 2031 Senior Notes, to variable interest rates based on three-month LIBOR plus a margin. This interest rate swap agreement was designated as a fair value hedge.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Mar. 31, 2021
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying consolidated financial statements include the accounts of The Estée Lauder Companies Inc. and its subsidiaries (collectively, the “Company”). All significant intercompany balances and transactions have been eliminated. The unaudited interim consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The unaudited interim consolidated financial statements furnished reflect all adjustments which are, in the opinion of management, necessary for a fair statement of the results for the interim periods presented. The results of operations of any interim period are not necessarily indicative of the results of operations to be expected for the full fiscal year. The interim consolidated financial statements should be read in conjunction with the consolidated financial statements and accompanying footnotes included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2020. Certain amounts in the consolidated financial statements of prior years have been reclassified to conform to current year presentation.
Management Estimates	Management Estimates The preparation of financial statements and related disclosures in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses reported in those financial statements. Descriptions of the Company’s significant accounting policies are discussed in the notes to consolidated financial statements in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2020. Management evaluates the related estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and makes adjustments when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ significantly from those estimates and assumptions. Significant changes, if any, in those estimates and assumptions resulting from continuing changes in the economic environment, including those related to the impacts of the COVID-19 pandemic, will be reflected in the consolidated financial statements in future periods.
Currency Translation and Transactions	Currency Translation and Transactions All assets and liabilities of foreign subsidiaries and affiliates are translated at period-end rates of exchange, while revenue and expenses are translated at monthly average rates of exchange for the period. Unrealized translation gains (losses), net of tax, reported as translation adjustments through other comprehensive income (loss) (“OCI”) attributable to The Estée Lauder Companies Inc. were $(143) million and $(173) million, net of tax, during the three months ended March 31, 2021 and 2020, respectively, and $175 million and $(170) million, net of tax, during the nine months ended March 31, 2021 and 2020, respectively. For the Company’s subsidiaries operating in highly inflationary economies, the U.S. dollar is the functional currency. Remeasurement adjustments in financial statements in a highly inflationary economy and other transactional gains and losses are reflected in earnings (loss). These subsidiaries are not material to the Company’s consolidated financial statements or liquidity. The Company enters into foreign currency forward contracts and may enter into option contracts to hedge foreign currency transactions for periods consistent with its identified exposures. The Company also enters into foreign currency forward contracts to hedge a portion of its net investment in certain foreign operations, which are designated as net investment hedges. See Note 6 – Derivative Financial Instruments for further discussion . The Company categorizes these instruments as entered into for purposes other than trading.
Concentration of Credit Risk	Concentration of Credit RiskThe Company is a worldwide manufacturer, marketer and distributor of skin care, makeup, fragrance and hair care products. The Company’s sales subject to credit risk are made primarily to department stores, perfumeries, specialty multi-brand retailers and retailers in its travel retail business. The Company grants credit to qualified customers. As a result of the COVID-19 pandemic, the Company has enhanced its assessment of its customers' abilities to pay with a greater focus on factors affecting their liquidity and less on historical payment performance. While the Company does not believe it is exposed significantly to any undue concentration of credit risk at this time, it continues to monitor the extent of the impact of the COVID-19 pandemic on its customers' abilities, individually and collectively, to make timely payments.
Property, Plant and Equipment	Property, Plant and Equipment Property, plant and equipment consists of the following: (In millions) March 31 June 30 Assets (Useful Life) Land $ 56 $ 33 Buildings and improvements (10 to 40 years) 467 400 Machinery and equipment (3 to 10 years) 946 865 Computer hardware and software (4 to 10 years) 1,374 1,335 Furniture and fixtures (5 to 10 years) 121 120 Leasehold improvements 2,397 2,381 5,361 5,134 Less accumulated depreciation and amortization (3,255) (3,079) $ 2,106 $ 2,055
Income Taxes	Income Taxes The effective rate for income taxes for the three and nine months ended March 31, 2021 and 2020 are as follows: Three Months Ended Nine Months Ended 2021 2020 2021 2020 Effective rate for income taxes 21.0 % 105.0 % 18.5 % 30.0 % Basis-point change from the prior-year period (8,400) (1,150) For the three and nine months ended March 31, 2021, the decrease in the effective tax rate was primarily attributable to the impact of nondeductible goodwill charges recognized in the three and nine months ended March 31, 2020 and a lower effective tax rate on the Company's foreign operations. The lower amount of earnings before income taxes for the three and nine months ended March 31, 2020 increased the impact of the nondeductible charges. The effective tax rate for the three and nine months ended March 31, 2021 included the impact of the U.S. government issuance of final global intangible low-taxed income (“GILTI”) tax regulations in July 2020 under the Tax Cuts and Jobs Act that provide for a high-tax exception to the GILTI tax. These regulations are retroactive to the original enactment of the GILTI tax provision, which includes the Company's 2019 and 2020 fiscal years. The Company has elected to apply the GILTI high-tax exception to fiscal 2021, 2020 and 2019. The election for fiscal 2021 resulted in reductions of 100 basis points and 110 basis points to the effective tax rates for the three and nine months ended March 31, 2021, respectively. The impact of the elections with respect to fiscal 2020 and 2019 was recognized as a discrete item in the provision for income taxes in the second and third quarters of fiscal 2021 and resulted in reductions of 30 basis points and 220 basis points to the effective tax rates for the three and nine months ended March 31, 2021, respectively. As of March 31, 2021 and June 30, 2020, the gross amount of unrecognized tax benefits, exclusive of interest and penalties, totaled $72 million and $70 million, respectively. The total amount of unrecognized tax benefits at March 31, 2021 that, if recognized, would affect the effective tax rate was $57 million. The total gross interest and penalties accrued related to unrecognized tax benefits during the three and nine months ended March 31, 2021 in the accompanying consolidated statements of earnings (loss) was $2 million and $3 million, respectively. The total gross accrued interest and penalties in the accompanying consolidated balance sheets at March 31, 2021 and June 30, 2020, was $16 million and $13 million, respectively. On the basis of the information available as of March 31, 2021, the Company does not expect significant changes to the total amount of unrecognized tax benefits within the next twelve months.
Recently Adopted and Issued Accounting Standards	Recently Adopted Accounting Standards Measurement of Credit Losses on Financial Instruments (ASC Topic 326 – Financial Instruments – Credit Losses) (“ASC 326”) In June 2016, the Financial Accounting Standards Board (“FASB”) issued authoritative guidance that requires companies to utilize an impairment model for most financial assets measured at amortized cost and certain other financial instruments, which include trade and other receivables, loans and held-to-maturity debt securities, to record an allowance for credit risk based on expected losses rather than incurred losses. In addition, this guidance changes the recognition method for credit losses on available-for-sale debt securities, which can occur as a result of market and credit risk, and requires additional disclosures. In general, modified retrospective adoption will be required for all outstanding instruments that fall under this guidance. In November 2019, the FASB issued authoritative guidance (ASU 2019-11 – Codification Improvements to Topic 326, Financial Instruments – Credit Losses) that amends ASC Topic 326 to clarify, improve and amend certain aspects of this guidance, such as disclosures related to accrued interest receivables and the estimation of credit losses associated with financial assets secured by collateral. In February 2020, the FASB issued authoritative guidance (ASU 2020-02 – Financial Instruments – Credit Losses (Topic 326) and Leases (Topic 842)) that amends and clarifies Topic 326 and Topic 842. For Topic 326, the codification was updated to include the Securities and Exchange Commission staff interpretations associated with registrants engaged in lending activities. Effective for the Company – Fiscal 2021 first quarter. Impact on consolidated financial statements – On July 1, 2020, the Company adopted ASC 326. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements. See Note 8 – Revenue Recognition for further discussion. Goodwill and Other – Internal-Use Software (ASU 2018-15 – Intangibles – Goodwill and Other – Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract) In August 2018, the FASB issued authoritative guidance that permits companies to capitalize the costs incurred for setting up business systems that operate on cloud technology. The new guidance aligns the requirement for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The guidance does not affect the accounting for the service element of a hosting arrangement that is a service contract. Capitalized costs associated with a hosting arrangement that is a service contract must be amortized over the term of the hosting arrangement to the same line item in the income statement as the expense for fees for the hosting arrangement. Effective for the Company – Fiscal 2021 first quarter, with early adoption permitted in any interim period. This guidance can be adopted either retrospectively, or prospectively to all implementation costs incurred after the date of adoption. Impact on consolidated financial statements – On July 1, 2020, the Company adopted this guidance prospectively to all implementation costs incurred after the date of adoption. The adoption of this standard did not have a material impact on the Company's consolidated financial statements. Recently Issued Accounting Standards Reference Rate Reform (ASC Topic 848) In March 2020, the FASB issued authoritative guidance to provide optional relief for companies preparing for the discontinuation of interest rates such as the London Interbank Offered Rate (“LIBOR”), which is expected to be phased out at the end of calendar 2021, and applies to lease contracts, hedging instruments, held-to-maturity debt securities and debt arrangements that have LIBOR as the benchmark rate. In January 2021, the FASB issued authoritative guidance that makes amendments to the new rules on accounting for reference rate reform. The amendments clarify that for all derivative instruments affected by the changes to interest rates used for discounting, margining or contract price alignment, regardless of whether they reference LIBOR or another rate expected to be discontinued as a result of reference rate reform, an entity may apply certain practical expedients in ASC Topic 848. Effective for the Company – This guidance can be applied for a limited time through December 31, 2022. The guidance will no longer be available to apply after December 31, 2022. Impact on consolidated financial statements – The Company is currently assessing the impact of applying this guidance on its existing derivative contracts, leases and other arrangements, as well as when to adopt this guidance. Income Taxes (ASU 2019-12 – Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes) In December 2019, the FASB issued authoritative guidance that simplifies the accounting for income taxes by removing certain exceptions and making simplifications in other areas. Effective for the Company – Fiscal 2022 first quarter, with early adoption permitted in any interim period. If adopted early, the Company must adopt all the amendments in the same period. The amendments have differing adoption methods including retrospectively, prospectively and/or modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the fiscal year of adoption, depending on the specific change. Impact on consolidated financial statements – The Company is in the process of finalizing its evaluation and currently expects to record a cumulative adjustment of approximately $120 million as an increase to its fiscal 2022 opening retained earnings balance for deferred taxes related to a previously held equity method investment that became a foreign subsidiary. No other recently issued accounting pronouncements are expected to have a material impact on the Company’s consolidated financial statements.

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	9 Months Ended
	Mar. 31, 2021
Accounting Policies [Abstract]
Schedule of inventory and promotional merchandise	Inventory and promotional merchandise consists of the following: (In millions) March 31 June 30 Raw materials $ 551 $ 542 Work in process 282 305 Finished goods 1,078 995 Promotional merchandise 223 220 $ 2,134 $ 2,062
Schedule of property, plant and equipment	Property, plant and equipment consists of the following: (In millions) March 31 June 30 Assets (Useful Life) Land $ 56 $ 33 Buildings and improvements (10 to 40 years) 467 400 Machinery and equipment (3 to 10 years) 946 865 Computer hardware and software (4 to 10 years) 1,374 1,335 Furniture and fixtures (5 to 10 years) 121 120 Leasehold improvements 2,397 2,381 5,361 5,134 Less accumulated depreciation and amortization (3,255) (3,079) $ 2,106 $ 2,055
Schedule of effective rate for income taxes	The effective rate for income taxes for the three and nine months ended March 31, 2021 and 2020 are as follows: Three Months Ended Nine Months Ended 2021 2020 2021 2020 Effective rate for income taxes 21.0 % 105.0 % 18.5 % 30.0 % Basis-point change from the prior-year period (8,400) (1,150)
Schedule of other accrued liabilities	Other accrued liabilities consist of the following: (In millions) March 31 June 30 Advertising, merchandising and sampling $ 299 $ 256 Employee compensation 534 424 Deferred revenue 310 222 Payroll and other taxes 287 250 Accrued income taxes 327 208 Sales return accrual 270 212 Other 1,050 833 $ 3,077 $ 2,405

GOODWILL AND OTHER INTANGIBLE_2

GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)	9 Months Ended
	Mar. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of goodwill by product category and related change in the carrying amount	The following table presents goodwill by product category and the related change in the carrying amount: (In millions) Skin Care Makeup Fragrance Hair Care Total Balance as of June 30, 2020 Goodwill $ 519 $ 1,210 $ 254 $ 389 $ 2,372 Accumulated impairments (95) (817) (26) (33) (971) 424 393 228 356 1,401 Goodwill acquired during the period — 6 — 4 10 Impairment charges (1) (54) (13) — — (67) Translation adjustments, goodwill 21 — 4 3 28 Translation adjustments, accumulated impairments (1) — — (2) (3) (34) (7) 4 5 (32) Balance as of March 31, 2021 Goodwill 540 1,216 258 396 2,410 Accumulated impairments (150) (830) (26) (35) (1,041) $ 390 $ 386 $ 232 $ 361 $ 1,369 (1) A goodwill impairment charge of $13 million was recorded in connection with the exit of the global distribution of BECCA products and is included in Restructuring and other charges in the accompanying consolidated statements of earnings (loss) for the three and nine months ended March 31, 2021. See Note 4 – Charges Associated with Restructuring and Other Activities for further information relating to the Post-COVID Business Acceleration Program. See “ Impairment Testing During the Nine Months Ended March 31, 2021 ” below for further information relating to fiscal 2021 impairment charges related to GLAMGLOW.
Schedule of other intangible assets, by type	Other intangible assets consist of the following: March 31, 2021 June 30, 2020 (In millions) Gross Accumulated Total Net Gross Accumulated Total Net Amortizable intangible assets: Customer lists and other $ 1,641 $ 564 $ 1,077 $ 1,590 $ 475 $ 1,115 License agreements 43 43 — 43 43 — $ 1,684 $ 607 1,077 $ 1,633 $ 518 1,115 Non-amortizable intangible assets: Trademarks and other 1,217 1,223 Total intangible assets $ 2,294 $ 2,338
Estimated aggregate amortization expense for the remainder of the current fiscal year and the next four years	The estimated aggregate amortization expense for the remainder of fiscal 2021 and for each of the next four fiscal years is as follows: Fiscal (In millions) 2021 2022 2023 2024 2025 Estimated aggregate amortization expense $ 24 $ 101 $ 100 $ 100 $ 100
Summary of impairment charges and carrying value of intangible assets	A summary of the impairment charges for the three and nine months ended March 31, 2020 and the remaining trademark and goodwill carrying values as of March 31, 2020, for each reporting unit, are as follows: Impairment Charge (In millions) Three Months Ended Nine Months Ended Carrying Value Reporting Unit: Product Category Region Trademark Goodwill Trademark Goodwill Trademark Goodwill Too Faced Makeup The Americas $ 42 $ 162 $ 253 $ 592 $ 272 $ 13 BECCA Makeup The Americas 14 35 47 70 51 28 Smashbox Makeup The Americas 1 26 23 72 32 — GLAMGLOW Skin care The Americas 1 52 1 52 62 62 Total $ 58 $ 275 $ 324 $ 786 $ 417 $ 103

CHARGES ASSOCIATED WITH RESTR_2

CHARGES ASSOCIATED WITH RESTRUCTURING AND OTHER ACTIVITIES (Tables)	9 Months Ended
	Mar. 31, 2021
Restructuring and Related Activities [Abstract]
Schedule of aggregate restructuring and other activities	Charges associated with restructuring activities for the three months ended March 31, 2021 were as follows: Sales Cost of Sales Operating Expenses Total (In millions) Restructuring Other Leading Beauty Forward Program $ — $ (1) $ 3 $ 4 $ 6 Post-COVID Business Acceleration Program 10 5 121 3 139 Total $ 10 $ 4 $ 124 $ 7 $ 145 Charges associated with restructuring activities for the nine months ended March 31, 2021 were as follows: Sales Cost of Sales Operating Expenses Total (In millions) Restructuring Other Leading Beauty Forward Program $ — $ 4 $ (7) $ 9 $ 6 Post-COVID Business Acceleration Program 10 5 167 3 185 Total $ 10 $ 9 $ 160 $ 12 $ 191
Schedule of total cumulative charges expected to be incurred associated with restructuring and other activities	The LBF Program approved restructuring and other charges expected to be incurred were: Sales Cost of Sales Operating Expenses Total (In millions) Restructuring Other Total Charges (Adjustments) Approved Cumulative through June 30, 2020 $ 13 $ 85 $ 511 $ 358 $ 967 Nine months ended March 31, 2021 1 — (11) 10 — Cumulative through March 31, 2021 $ 14 $ 85 $ 500 $ 368 $ 967 The PCBA Program cumulative charges approved by the Company through March 31, 2021 were: Sales Cost of Sales Operating Expenses Total (In millions) Restructuring Other Total Charges (Adjustments) Approved Nine months ended March 31, 2021 $ 39 $ (6) $ 180 $ 17 $ 230
Schedule of total cumulative charges by type approved associated with restructuring initiatives	Included in the above table, cumulative LBF Program restructuring initiatives approved by the Company by major cost type were: (In millions) Employee- Asset- Contract Other Exit Total Restructuring Charges (Adjustments) Approved Cumulative through June 30, 2020 $ 460 $ 28 $ 7 $ 16 $ 511 Nine months ended March 31, 2021 (13) — 2 — (11) Cumulative through March 31, 2021 $ 447 $ 28 $ 9 $ 16 $ 500 Included in the above table, cumulative PCBA Program restructuring initiatives approved by the Company through March 31, 2021 by major cost type were: (In millions) Employee- Asset- Contract Other Exit Total Restructuring Charges Approved Nine months ended March 31, 2021 $ 73 $ 99 $ 5 $ 3 $ 180
Schedule of total cumulative charges recorded associated with restructuring and other activities	Total cumulative charges recorded associated with restructuring and other activities for the LBF Program were: (In millions) Sales Cost of Sales Operating Expenses Total Restructuring Other Total Charges (Adjustments) Cumulative through June 30, 2020 $ 14 $ 65 $ 491 $ 304 $ 874 Nine months ended March 31, 2021 — 4 (7) 9 6 Cumulative through March 31, 2021 $ 14 $ 69 $ 484 $ 313 $ 880 Sales Cost of Sales Operating Expenses Total (In millions) Restructuring Other Total Charges Nine months ended March 31, 2021 $ 10 $ 5 $ 167 $ 3 $ 185
Schedule of total cumulative charges by type recorded associated with restructuring and other activities	(In millions) Employee- Asset- Contract Other Exit Total Restructuring Charges (Adjustments) Cumulative through June 30, 2020 $ 451 $ 27 $ 6 $ 7 $ 491 Nine months ended March 31, 2021 (10) — 1 2 (7) Cumulative through March 31, 2021 $ 441 $ 27 $ 7 $ 9 $ 484 (In millions) Employee- Asset- Related Costs (1) Contract Other Exit Total Restructuring Charges Nine months ended March 31, 2021 $ 70 $ 93 $ 4 $ — $ 167 (1) Asset-related costs include goodwill and other intangible asset impairment charges of $13 million and $34 million, respectively, relating to the exit of the global distribution of BECCA products.
Schedule of changes in accrued restructuring charges	Changes in accrued restructuring charges for the nine months ended March 31, 2021 relating to the LBF Program were: (In millions) Employee- Asset- Contract Other Exit Total Balance at June 30, 2020 $ 112 $ — $ — $ — $ 112 Charges (adjustments) (10) — 1 2 (7) Cash payments (50) — (1) — (51) Translation adjustments 1 — — — 1 Balance at March 31, 2021 $ 53 $ — $ — $ 2 $ 55 Changes in accrued restructuring charges for the nine months ended March 31, 2021 relating to the PCBA Program were: (In millions) Employee- Asset- Contract Other Exit Total Charges $ 70 $ 93 $ 4 $ — $ 167 Cash payments (8) — (4) — (12) Noncash asset write-offs — (93) — — (93) Balance at March 31, 2021 $ 62 $ — $ — $ — $ 62

DEBT (Tables)

DEBT (Tables)	9 Months Ended
	Mar. 31, 2021
Debt Disclosure [Abstract]
Schedule of long-term debt	These recently issued notes are summarized as follows: ($ in millions) Issue Date Price Yield Unamortized Debt Semi-annual 2031 Senior Notes (1) March 2021 99.340 % 2.023 % $ (4) $ (4) March 15/September 15 (1) In March 2020, in anticipation of the issuance of the 2031 Senior Notes, the Company entered into a series of treasury lock agreements on a notional amount totaling $200 million at a weighted-average all-in rate of 0.84%. The treasury lock agreements were settled upon the issuance of the new debt, and the Company recognized a gain in OCI of $11 million that is being amortized to interest expense over the life of the 2031 Senior Notes. As a result of the treasury lock agreements, as well as the debt discount and debt issuance costs, the effective interest rate on the 2031 Senior Notes will be 1.89% over the life of the debt.

DERIVATIVE FINANCIAL INSTRUME_2

DERIVATIVE FINANCIAL INSTRUMENTS (Tables)	9 Months Ended
	Mar. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of fair values of the derivative financial instruments included in the consolidated balance sheets	The fair values of the Company’s derivative financial instruments included in the consolidated balance sheets are presented as follows: Asset Derivatives Liability Derivatives Fair Value (1) Fair Value (1) (In millions) Balance Sheet March 31 June 30 Balance Sheet March 31 June 30 Derivatives Designated as Hedging Instruments Foreign currency cash flow hedges Prepaid expenses and other current assets $ 16 $ 26 Other accrued liabilities $ 21 $ 3 Net investment hedges Prepaid expenses and other current assets 115 21 Other accrued liabilities — 62 Interest rate-related derivatives Prepaid expenses and other current assets 7 15 Other accrued liabilities 15 3 Total Derivatives Designated as Hedging Instruments 138 62 36 68 Derivatives Not Designated as Hedging Instruments Foreign currency forward contracts Prepaid expenses and other current assets 5 40 Other accrued liabilities 108 15 Total derivatives $ 143 $ 102 $ 144 $ 83 (1) See Note 7 – Fair Value Measurements for further information about how the fair value of derivative assets and liabilities are determined.
Schedule of gains and losses related to derivative financial instruments designated as hedging instruments that are included in the assessment of effectiveness	The amounts of the gains and losses related to the Company’s derivative financial instruments designated as hedging instruments that are included in the assessment of effectiveness are as follows: Amount of Gain (Loss) Location of Gain (Loss) Amount of Gain (Loss) Reclassified from AOCI into Earnings (Loss) (1) Three Months Ended Three Months Ended (In millions) 2021 2020 2021 2020 Derivatives in Cash Flow Hedging Relationships: Foreign currency forward contracts $ 22 $ 46 Net sales $ (7) $ 10 Interest rate-related derivatives 11 (2) Interest expense (1) — 33 44 (8) 10 Derivatives in Net Investment Hedging Relationships (2) : Foreign currency forward contracts (3) 125 (20) — — Total derivatives $ 158 $ 24 $ (8) $ 10 (1) The amount reclassified into earnings (loss) as a result of the discontinuance of cash flow hedges because probable forecasted transactions will no longer occur by the end of the original time period was not material. (2) During the three months ended March 31, 2021 and 2020, the gain recognized in earnings (loss) from net investment hedges related to the amount excluded from effectiveness testing was $5 million and $12 million, respectively. (3) Included within translation adjustments as a component of AOCI on the Company’s consolidated balance sheets. Amount of Gain (Loss) Location of Gain (Loss) Amount of Gain (Loss) Reclassified from AOCI into Earnings (1) Nine Months Ended Nine Months Ended (In millions) 2021 2020 2021 2020 Derivatives in Cash Flow Hedging Relationships: Foreign currency forward contracts $ (43) $ 50 Net sales $ (11) $ 29 Interest rate-related derivatives 14 (11) Interest expense (2) — (29) 39 (13) 29 Derivatives in Net Investment Hedging Relationships (2) : Foreign currency forward contracts (3) (17) (54) — — Total derivatives $ (46) $ (15) $ (13) $ 29 (1) The amount reclassified into earnings as a result of the discontinuance of cash flow hedges because probable forecasted transactions will no longer occur by the end of the original time period was not material. (2) During the nine months ended March 31, 2021 and 2020, the gain recognized in earnings from net investment hedges related to the amount excluded from effectiveness testing was $15 million and $37 million, respectively. (3) Included within translation adjustments as a component of AOCI on the Company’s consolidated balance sheets. Amount of Gain (Loss) Recognized in Earnings (Loss) on Derivatives (1) Location of Gain (Loss) Recognized in Earnings (Loss) on Derivatives Three Months Ended Nine Months Ended (In millions) 2021 2020 2021 2020 Derivatives in Fair Value Hedging Relationships: Interest rate swap contracts Interest expense $ (18) $ 12 $ (23) $ 13 (1) Changes in the fair value of the interest rate swap agreements are exactly offset by the change in the fair value of the underlying long-term debt.
Schedule of cumulative amount of fair value hedging adjustments for designated and qualifying hedged items	Additional information regarding the cumulative amount of fair value hedging gain (loss) recognized in earnings for items designated and qualifying as hedged items in fair value hedges is as follows: (In millions) Line Item in the Consolidated Balance Sheets in Carrying Amount of the Cumulative Amount of Fair March 31, 2021 March 31, 2021 Current debt $ 451 $ 1 Long-term debt 936 (9) Total debt $ 1,387 $ (8)
Schedule of effects of fair value and cash flow hedging relationships for designated and qualified hedging instruments	Additional information regarding the effects of fair value and cash flow hedging relationships for derivatives designated and qualifying as hedging instruments is as follows: Three Months Ended March 31 2021 2020 (In millions) Net Sales Interest Net Sales Interest Total amounts of income and expense line items presented in the consolidated statements of earnings (loss) in which the effects of fair value and cash flow hedges are recorded $ 3,864 $ 43 $ 3,345 $ 42 The effects of fair value and cash flow hedging relationships: Gain (loss) on fair value hedge relationships – interest rate contracts: Hedged item Not applicable 18 Not applicable (12) Derivatives designated as hedging instruments Not applicable (18) Not applicable 12 Gain (loss) on cash flow hedge relationships – interest rate contracts: Amount of loss reclassified from AOCI into earnings (loss) Not applicable (1) Not applicable — Gain (loss) on cash flow hedge relationships – foreign currency forward contracts: Amount of gain reclassified from AOCI into earnings (loss) (7) Not applicable 10 Not applicable Nine Months Ended March 31 2021 2020 (In millions) Net Sales Interest Net Sales Interest Total amounts of income and expense line items presented in the consolidated statements of earnings in which the effects of fair value and cash flow hedges are recorded $ 12,279 $ 131 $ 11,864 $ 112 The effects of fair value and cash flow hedging relationships: Gain (loss) on fair value hedge relationships – interest rate contracts: Hedged item Not applicable 23 Not applicable (13) Derivatives designated as hedging instruments Not applicable (23) Not applicable 13 Gain (loss) on cash flow hedge relationships – interest rate contracts: Amount of loss reclassified from AOCI into earnings Not applicable (2) Not applicable — Gain (loss) on cash flow hedge relationships – foreign currency forward contracts: Amount of gain reclassified from AOCI into earnings (11) Not applicable 29 Not applicable
Schedule of gains and losses related to derivative financial instruments not designated as hedging instruments	The amount of gains and losses related to the Company’s derivative financial instruments not designated as hedging instruments are presented as follows: Amount of Gain (Loss) Location of Gain (Loss) Recognized in Earnings (Loss) on Derivatives Three Months Ended Nine Months Ended (In millions) 2021 2020 2021 2020 Derivatives Not Designated as Hedging Instruments: Foreign currency forward contracts Selling, general and administrative $ (97) $ 49 $ (34) $ 52

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	9 Months Ended
	Mar. 31, 2021
Fair Value Disclosures [Abstract]
Schedule of financial assets and liabilities measured at fair value on a recurring basis	The following table presents the Company’s hierarchy for its financial assets and liabilities measured at fair value on a recurring basis as of March 31, 2021: (In millions) Level 1 Level 2 Level 3 Total Assets: Money market funds $ 3,518 $ — $ — $ 3,518 Foreign currency forward contracts — 136 — 136 Interest rate-related derivatives — 7 — 7 Total $ 3,518 $ 143 $ — $ 3,661 Liabilities: Foreign currency forward contracts $ — $ 129 $ — $ 129 Interest rate-related derivatives — 15 — 15 Contingent consideration — — 2 2 Total $ — $ 144 $ 2 $ 146 The following table presents the Company’s hierarchy for its financial assets and liabilities measured at fair value on a recurring basis as of June 30, 2020: (In millions) Level 1 Level 2 Level 3 Total Assets: Money market funds $ 2,810 $ — $ — $ 2,810 Foreign currency forward contracts — 87 — 87 Interest rate-related derivatives — 15 — 15 Total $ 2,810 $ 102 $ — $ 2,912 Liabilities: Foreign currency forward contracts $ — $ 80 $ — $ 80 Interest rate-related derivatives — 3 — 3 Contingent consideration — — 4 4 Total $ — $ 83 $ 4 $ 87
Schedule of estimated fair values of financial instruments	The estimated fair values of the Company’s financial instruments are as follows: March 31 June 30 (In millions) Carrying Fair Carrying Fair Nonderivatives Cash and cash equivalents $ 6,399 $ 6,399 $ 5,022 $ 5,022 Current and long-term debt 5,958 6,465 6,136 6,902 Contingent consideration 2 2 4 4 Derivatives Foreign currency forward contracts – asset (liability), net 7 7 7 7 Interest rate-related derivatives – asset (liability), net (8) (8) 12 12
Impairment charges measured at fair value on a nonrecurring basis, classified as Level 3	The following table presents the Company’s impairment charges for the nine months ended March 31, 2021 for certain of its nonfinancial assets measured at fair value on a nonrecurring basis, classified as Level 3, due to a change in circumstances that triggered an interim impairment test: (In millions) Impairment charges Date of Fair Value Measurement Fair Value (1) Goodwill GLAMGLOW $ 54 November 30, 2020 $ — BECCA (2) 13 February 28, 2021 — Total 67 — Other intangible assets, net (trademark and customer lists) GLAMGLOW 27 November 30, 2020 36 BECCA (2) 34 February 28, 2021 — Total 61 36 Long-lived assets 33 March 31, 2021 35 Total $ 161 $ 71 (1) See Note 3 - Goodwill and Other Intangible Assets for discussion of the valuation techniques used to measure fair value, the description of the inputs and information used to develop those inputs. (2) See Note 4 – Charges Associated with Restructuring and Other Activities for further information relating to goodwill and other intangible asset impairment charges recorded in connection with the exit of the global distribution of BECCA products. The following table presents the Company’s impairment charges for the nine months ended March 31, 2020 for certain of its nonfinancial assets measured at fair value on a nonrecurring basis, classified as Level 3, due to a change in circumstances that triggered an interim impairment test: (In millions) Impairment charges Date of Fair Value Measurement Fair Value (1) Goodwill $ 786 March 31, 2020 $ 103 Other intangible assets, net (trademark) 324 March 31, 2020 417 Long-lived assets 13 March 31, 2020 11 Total $ 1,123 $ 531 (1) See Note 3 - Goodwill and Other Intangible Assets for discussion of the valuation techniques used to measure fair value, the description of the inputs and information used to develop those inputs.
Changes in the fair value of the contingent consideration obligations	Changes in the fair value of the contingent consideration obligations for nine months ended March 31, 2021 are included in Selling, general and administrative expenses in the accompanying consolidated statements of earnings (loss) and were as follows: (In millions) Fair Value Contingent consideration at June 30, 2020 $ 4 Changes in fair value (2) Contingent consideration at March 31, 2021 $ 2

REVENUE RECOGNITION (Tables)

REVENUE RECOGNITION (Tables)	9 Months Ended
	Mar. 31, 2021
Revenue from Contract with Customer [Abstract]
Schedule of changes in allowance for credit losses	Changes in the allowance for credit losses are as follows: (In millions) Balance at June 30, 2020 $ 36 ASC 326 cumulative effect adjustment (pre-tax) 4 Adjustment for expected credit losses (5) Write-offs, net & other (10) Balance at March 31, 2021 $ 25
Schedule of significant changes in deferred revenue	Changes in deferred revenue during the period are as follows: Three Months Ended Nine Months Ended (In millions) 2021 2020 2021 2020 Deferred revenue, beginning of period $ 420 $ 425 $ 279 $ 361 Revenue recognized that was included in the deferred revenue balance at the beginning of the period (25) (26) (198) (268) Revenue deferred (released) during the period (30) (37) 278 269 Other (4) — 2 — Deferred revenue, end of period $ 361 $ 362 $ 361 $ 362

PENSION AND POST-RETIREMENT B_2

PENSION AND POST-RETIREMENT BENEFIT PLANS (Tables)	9 Months Ended
	Mar. 31, 2021
Retirement Benefits [Abstract]
Schedule of components of net periodic benefit cost for pension and other post-retirement benefit plans	The components of net periodic benefit cost for the three months ended March 31, 2021 and 2020 consisted of the following: Pension Plans Other than U.S. International Post-retirement (In millions) 2021 2020 2021 2020 2021 2020 Service cost $ 12 $ 9 $ 9 $ 9 $ 2 $ — Interest cost 8 9 2 3 1 2 Expected return on plan assets (14) (14) (4) (4) (1) — Amortization of: Actuarial loss 5 5 1 1 — — Settlements — — 1 — — — Special termination benefits — — 1 1 — — Net periodic benefit cost $ 11 $ 9 $ 10 $ 10 $ 2 $ 2 The components of net periodic benefit cost for the nine months ended March 31, 2021 and 2020 consisted of the following: Pension Plans Other than U.S. International Post-retirement (In millions) 2021 2020 2021 2020 2021 2020 Service cost $ 34 $ 29 $ 27 $ 27 $ 2 $ 2 Interest cost 23 26 7 8 4 5 Expected return on plan assets (40) (40) (10) (11) (1) (1) Amortization of: Actuarial loss 15 12 3 4 — — Settlements — — 1 — — — Special termination benefits — — 10 1 — — Net periodic benefit cost $ 32 $ 27 $ 38 $ 29 $ 5 $ 6
Schedule of amounts recognized in the consolidated balance sheets related to the Company's pension and post-retirement benefit plans	The amounts recognized in the consolidated balance sheets related to the Company’s pension and post-retirement benefit plans consist of the following: (In millions) March 31 June 30 Other assets $ 137 $ 127 Other accrued liabilities (27) (27) Other noncurrent liabilities (470) (440) Funded status (360) (340) Accumulated other comprehensive loss 304 324 Net amount recognized $ (56) $ (16)

STOCK PROGRAMS (Tables)

STOCK PROGRAMS (Tables)	9 Months Ended
	Mar. 31, 2021
Share-based Payment Arrangement [Abstract]
Schedule of Long-term Price Vested Units	The number of shares subject to each tranche of the price-vested unit award, as well as the stock price goals, service periods, performance periods and share delivery dates for each tranche are as follows: Number Stock Price Goal Service Period Performance Period for Stock Price Goal Performance Period for Cumulative Operating Income Goal Share Delivery Date First tranche 27,457 $ 323.03 March 11, 2021 - June 30, 2024 March 11, 2021 - June 30, 2024 July 1, 2021 - June 30, 2025 September 2, 2025 Second tranche 28,598 $ 333.21 March 11, 2021 - June 30, 2024 March 11, 2021 - June 30, 2024 July 1, 2021 - June 30, 2025 September 2, 2025 Third tranche 29,872 $ 343.61 March 11, 2021 - June 30, 2024 March 11, 2021 - June 30, 2024 July 1, 2021 - June 30, 2025 September 2, 2025 Total shares 85,927
Schedule of Assumptions Used for Award	The assumptions used for this award were as follows: Expected volatility 31.8 % Dividend yield 0.8 % Risk-free interest rate 0.4 % Expected term 3.3 years

NET EARNINGS (LOSS) ATTRIBUTA_2

NET EARNINGS (LOSS) ATTRIBUTABLE TO THE ESTEE LAUDER COMPANIES INC. PER COMMON SHARE (Tables)	9 Months Ended
	Mar. 31, 2021
Earnings Per Share [Abstract]
Schedule of reconciliation between the numerator and denominator of the basic and diluted EPS computations	A reconciliation between the numerator and denominator of the basic and diluted EPS computations is as follows: Three Months Ended Nine Months Ended (In millions, except per share data) 2021 2020 2021 2020 Numerator: Net earnings (loss) attributable to The Estée Lauder Companies Inc. $ 456 $ (6) $ 1,852 $ 1,146 Denominator: Weighted-average common shares outstanding – Basic 363.6 360.2 362.9 360.6 Effect of dilutive stock options (1) 4.1 — 3.9 4.6 Effect of PSUs (1) 0.2 — 0.2 0.3 Effect of RSUs (1) 1.1 — 1.1 1.6 Weighted-average common shares outstanding – Diluted 369.0 360.2 368.1 367.1 Net earnings (loss) attributable to The Estée Lauder Companies Inc. per common share: Basic $ 1.25 $ (.02) $ 5.10 $ 3.18 Diluted $ 1.24 $ (.02) $ 5.03 $ 3.12
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	The shares of Class A Common Stock underlying stock options, RSUs and PSUs that were excluded in the computation of diluted EPS because their inclusion would be anti-dilutive were as follows: Three Months Ended Nine Months Ended (In millions) 2021 2020 2021 2020 Stock options (1) — — 0.9 1.3 RSUs and PSUs (1) — — 0.1 —

EQUITY (Tables)

EQUITY (Tables)	9 Months Ended
	Mar. 31, 2021
Equity [Abstract]
Schedule of equity	Total Stockholders’ Equity – The Estée Lauder Companies Inc. Three Months Ended Nine Months Ended (In millions) 2021 2020 2021 2020 Common stock, beginning of the period $ 6 $ 6 $ 6 $ 6 Stock-based compensation — — — — Common stock, end of the period 6 6 6 6 Paid-in capital, beginning of the period 5,068 4,615 4,790 4,403 Common stock dividends 1 1 2 3 Stock-based compensation 162 144 439 354 Paid-in capital, end of the period 5,231 4,760 5,231 4,760 Retained earnings, beginning of the period 11,159 10,775 10,134 9,984 Common stock dividends (195) (174) (563) (506) Net earnings (loss) attributable to The Estée Lauder Companies Inc. 456 (6) 1,852 1,146 Cumulative effect of adoption of new accounting standards — — (3) (29) Retained earnings, end of the period 11,420 10,595 11,420 10,595 Accumulated other comprehensive loss, beginning of the period (383) (569) (665) (563) Other comprehensive income (loss) (104) (143) 178 (149) Accumulated other comprehensive loss, end of the period (487) (712) (487) (712) Treasury stock, beginning of the period (10,429) (10,253) (10,330) (9,444) Acquisition of treasury stock (212) (65) (212) (768) Stock-based compensation (1) (2) (100) (108) Treasury stock, end of the period (10,642) (10,320) (10,642) (10,320) Total stockholders’ equity – The Estée Lauder Companies Inc. 5,528 4,329 5,528 4,329 Noncontrolling interests, beginning of the period 35 27 27 25 Net earnings attributable to noncontrolling interests 2 2 8 9 Distribution to noncontrolling interest holders (6) — (6) (4) Other comprehensive (income) loss (1) — 1 (1) Noncontrolling interests, end of the period 30 29 30 29 Total equity $ 5,558 $ 4,358 $ 5,558 $ 4,358 Cash dividends declared per common share $ .53 $ .48 $ 1.54 $ 1.39
Summary of cash dividends declared per share on the Company's Class A and Class B Common Stock	The following is a summary of quarterly cash dividends declared per share on the Company’s Class A and Class B Common Stock during the nine months ended March 31, 2021: Date Declared Record Date Payable Date Amount per Share August 19, 2020 August 31, 2020 September 15, 2020 $ .48 October 30, 2020 November 30, 2020 December 15, 2020 $ .53 February 4, 2021 February 26, 2021 March 15, 2021 $ .53
Schedule of components of AOCI, net of tax	The following table represents changes in AOCI, net of tax, by component for the nine months ended March 31, 2021: (In millions) Net Cash Retirement Plan and Other Retiree Benefit Adjustments Translation Total Balance at June 30, 2020 $ 14 $ (244) $ (435) $ (665) OCI before reclassifications (22) 1 (1) 175 (2) 154 Amounts reclassified to Net earnings 10 14 — 24 Net current-period OCI (12) 15 175 178 Balance at March 31, 2021 $ 2 $ (229) $ (260) $ (487) (1) Consists of foreign currency translation gains. (2) See Note 6 – Derivative Financial Instruments for gains (losses) relating to net investment hedges.
Schedule of effects of reclassification adjustments from AOCI into net earnings	The following table represents the effects of reclassification adjustments from AOCI into net earnings (loss) for the three and nine months ended March 31, 2021 and 2020: Amount Reclassified from AOCI Affected Line Item in Three Months Ended Nine Months Ended (In millions) 2021 2020 2021 2020 Gain (Loss) on Cash Flow Hedges Foreign currency forward contracts $ (7) $ 10 $ (11) $ 29 Net sales Interest rate-related derivatives (1) — (2) — Interest expense (8) 10 (13) 29 Benefit (provision) for deferred taxes 2 (2) 3 (7) Provision for income taxes $ (6) $ 8 (10) $ 22 Net earnings (loss) Retirement Plan and Other Retiree Benefit Adjustments Amortization of actuarial loss $ (6) $ (6) $ (18) $ (16) Other components of net periodic benefit cost (1) Settlements (1) — (1) — Other components of net periodic benefit cost (1) (7) (6) (19) (16) Earnings before income taxes (1) Benefit for deferred taxes 3 1 5 3 Provision for income taxes $ (4) $ (5) $ (14) $ (13) Net earnings (loss) Cumulative Translation Adjustments Gain on previously held equity method investment $ — $ — $ — $ 4 Other income Loss on liquidation of an investment in a foreign subsidiary — — — (6) Restructuring and other charges $ — $ — — $ (2) Net earnings (loss) Total reclassification adjustments, net $ (10) $ 3 $ (24) $ 7 Net earnings (loss) (1) See Note 9 – Pension and Post-Retirement Benefit Plans for additional information.

STATEMENT OF CASH FLOWS (Tables

STATEMENT OF CASH FLOWS (Tables)	9 Months Ended
	Mar. 31, 2021
Supplemental Cash Flow Elements [Abstract]
Supplemental cash flow information	Supplemental cash flow information for the nine months ended March 31, 2021 and 2020 is as follows: (In millions) 2021 2020 Cash: Cash paid during the period for interest $ 108 $ 94 Cash paid during the period for income taxes $ 435 $ 472 Non-cash investing and financing activities: Property, plant and equipment accrued but unpaid $ 68 $ 47 Right-of-use assets obtained in exchange for new operating lease liabilities $ 167 $ 216

SEGMENT DATA AND RELATED INFO_2

SEGMENT DATA AND RELATED INFORMATION (Tables)	9 Months Ended
	Mar. 31, 2021
Segment Reporting [Abstract]
Schedule of segment data and related information	Three Months Ended Nine Months Ended (In millions) 2021 2020 2021 2020 PRODUCT CATEGORY DATA Net sales: Skin Care $ 2,259 $ 1,723 $ 7,113 $ 5,770 Makeup 1,018 1,146 3,243 4,249 Fragrance 454 349 1,478 1,392 Hair Care 128 119 418 417 Other 15 8 37 36 3,874 3,345 12,289 11,864 Returns associated with restructuring and other activities (10) — (10) — Net sales $ 3,864 $ 3,345 $ 12,279 $ 11,864 Operating income (loss) before charges associated with restructuring and other activities: Skin Care $ 804 $ 418 $ 2,453 $ 1,822 Makeup (72) (283) (115) (790) Fragrance 47 — 248 163 Hair Care (17) (2) (10) 10 Other (1) 1 (1) 7 761 134 2,575 1,212 Reconciliation: Charges associated with restructuring and other activities (145) (25) (191) (63) Interest expense (43) (42) (131) (112) Interest income and investment income, net 9 14 40 41 Other components of net periodic benefit cost (2) (1) (12) (3) Other income — — — 576 Earnings before income taxes $ 580 $ 80 $ 2,281 $ 1,651 GEOGRAPHIC DATA (1) Net sales: The Americas $ 916 $ 892 $ 2,837 $ 3,278 Europe, the Middle East & Africa 1,706 1,525 5,276 5,281 Asia/Pacific 1,252 928 4,176 3,305 3,874 3,345 12,289 11,864 Returns associated with restructuring and other activities (10) — (10) — Net sales $ 3,864 $ 3,345 $ 12,279 $ 11,864 Operating income (loss): The Americas $ 155 $ (217) $ 256 $ (571) Europe, the Middle East & Africa 361 202 1,429 1,084 Asia/Pacific 245 149 890 699 761 134 2,575 1,212 Charges associated with restructuring and other activities (145) (25) (191) (63) Operating income $ 616 $ 109 $ 2,384 $ 1,149

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Currency Translation and Transactions (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Mar. 31, 2021	Mar. 31, 2020
Currency Translation and Transactions
Unrealized translation gains (losses), net of tax	$ (143)	$ (173)	$ 175	$ (170)
Net exchange gains (losses) on foreign currency transactions	$ (3)	$ 15	$ (5)	$ 40

SUMMARY OF SIGNIFICANT ACCOUN_5

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Concentration of Credit Risk (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended		12 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Mar. 31, 2021	Mar. 31, 2020	Jun. 30, 2020
Concentration Risk [Line Items]
Net sales	$ 3,864	$ 3,345	$ 12,279	$ 11,864
Accounts receivable, net	1,735		1,735		$ 1,194
Largest Customer | Revenue Benchmark | Customer Concentration Risk
Concentration Risk [Line Items]
Net sales	$ 690	$ 143	$ 1,898	$ 608
Concentration risk (as a percent)	18.00%	4.00%	15.00%	5.00%
Largest Customer | Accounts Receivable | Customer Concentration Risk
Concentration Risk [Line Items]
Accounts receivable, net	$ 366		$ 366		$ 297
Concentration risk (as a percent)			21.00%		24.00%
Other Major Customer | Revenue Benchmark | Customer Concentration Risk
Concentration Risk [Line Items]
Net sales	$ 167	$ 149	$ 510	$ 589
Concentration risk (as a percent)	4.00%	4.00%	4.00%	5.00%
Other Major Customer | Accounts Receivable | Customer Concentration Risk
Concentration Risk [Line Items]
Accounts receivable, net	$ 179		$ 179		$ 87
Concentration risk (as a percent)			10.00%		7.00%

SUMMARY OF SIGNIFICANT ACCOUN_6

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Inventory and Promotional Merchandise (Details) - USD ($) $ in Millions	Mar. 31, 2021	Jun. 30, 2020
Accounting Policies [Abstract]
Raw materials	$ 551	$ 542
Work in process	282	305
Finished goods	1,078	995
Promotional merchandise	223	220
Inventory and promotional merchandise	$ 2,134	$ 2,062

SUMMARY OF SIGNIFICANT ACCOUN_7

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Property, Plant and Equipment (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Mar. 31, 2021	Mar. 31, 2020	Jun. 30, 2020
Property, Plant and Equipment
Property, plant and equipment, gross	$ 5,361		$ 5,361		$ 5,134
Less accumulated depreciation and amortization	(3,255)		(3,255)		(3,079)
Property, plant and equipment, net	2,106		2,106		2,055
Cost of assets related to projects in progress	581		581		501
Depreciation and amortization of property, plant and equipment	129	$ 131	380	$ 383
Land
Property, Plant and Equipment
Property, plant and equipment, gross	56		56		33
Buildings and improvements
Property, Plant and Equipment
Property, plant and equipment, gross	467		$ 467		400
Buildings and improvements | Minimum
Property, Plant and Equipment
Property, plant and equipment, useful life (in years)			10 years
Buildings and improvements | Maximum
Property, Plant and Equipment
Property, plant and equipment, useful life (in years)			40 years
Machinery and equipment
Property, Plant and Equipment
Property, plant and equipment, gross	946		$ 946		865
Machinery and equipment | Minimum
Property, Plant and Equipment
Property, plant and equipment, useful life (in years)			3 years
Machinery and equipment | Maximum
Property, Plant and Equipment
Property, plant and equipment, useful life (in years)			10 years
Computer hardware and software
Property, Plant and Equipment
Property, plant and equipment, gross	1,374		$ 1,374		1,335
Computer hardware and software | Minimum
Property, Plant and Equipment
Property, plant and equipment, useful life (in years)			4 years
Computer hardware and software | Maximum
Property, Plant and Equipment
Property, plant and equipment, useful life (in years)			10 years
Furniture and fixtures
Property, Plant and Equipment
Property, plant and equipment, gross	121		$ 121		120
Furniture and fixtures | Minimum
Property, Plant and Equipment
Property, plant and equipment, useful life (in years)			5 years
Furniture and fixtures | Maximum
Property, Plant and Equipment
Property, plant and equipment, useful life (in years)			10 years
Leasehold improvements
Property, Plant and Equipment
Property, plant and equipment, gross	$ 2,397		$ 2,397		$ 2,381

SUMMARY OF SIGNIFICANT ACCOUN_8

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Leases (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Mar. 31, 2021	Mar. 31, 2020
Other Asset Impairment Charges
LEASES
Operating lease, impairment loss	$ 33	$ 13	$ 33	$ 13

SUMMARY OF SIGNIFICANT ACCOUN_9

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Mar. 31, 2021	Mar. 31, 2020	Jun. 30, 2020
Income Tax Examination [Line Items]
Effective tax rate (as a percent)	21.00%	105.00%	18.50%	30.00%
Increase (decrease) in effective tax rate (as a percent)	(84.00%)		(11.50%)
Gross unrecognized tax benefits	$ 72		$ 72		$ 70
Total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate	57		57
Gross interest and penalty accrued	2		3
Total gross accrued interest and penalties related to unrecognized tax benefits	$ 16		$ 16		$ 13
Internal Revenue Service (IRS) | Fiscal Year 2021
Income Tax Examination [Line Items]
Tax cuts and jobs act, change in enacted rate after application of GILTI (as a percent)	(1.00%)		(1.10%)
Internal Revenue Service (IRS) | Fiscal Year 2020 and 2019
Income Tax Examination [Line Items]
Tax cuts and jobs act, change in enacted rate after application of GILTI (as a percent)	(0.30%)		(2.20%)

SUMMARY OF SIGNIFICANT ACCOU_10

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Other Accrued Liabilities (Details) - USD ($) $ in Millions	Mar. 31, 2021	Jun. 30, 2020
Accounting Policies [Abstract]
Advertising, merchandising and sampling	$ 299	$ 256
Employee compensation	534	424
Deferred revenue	310	222
Payroll and other taxes	287	250
Accrued income taxes	327	208
Sales return accrual	270	212
Other	1,050	833
Other accrued liabilities	$ 3,077	$ 2,405

SUMMARY OF SIGNIFICANT ACCOU_11

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Recently Adopted and Issued Accounting Standards (Details) - USD ($) $ in Millions	Jul. 01, 2021	Mar. 31, 2021	Jun. 30, 2020
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Retained earnings		$ 11,420	$ 10,134
Cumulative Effect, Period of Adoption, Adjustment | Forecast | Accounting Standards Update 2019-12
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Retained earnings	$ 120

ACQUISITION OF BUSINESS (Detail

ACQUISITION OF BUSINESS (Details) - USD ($) $ in Millions	Dec. 18, 2019	Mar. 31, 2020	Jun. 30, 2020
Acquisition of Business
Purchase price refund receivable			$ 32
Have & Be
Acquisition of Business
Interest acquired (as a percent)	66.66%
Cash consideration	$ 1,268
Carrying value	133
Fair value	682
Gain on remeasurement of previously held equity method investments	549
Recognition of previously unrealized foreign currency gain	$ 4
Have & Be | Other income
Acquisition of Business
Gain on remeasurement of equity method investment		$ 553
Foreign currency gain		$ 23

GOODWILL AND OTHER INTANGIBLE_3

GOODWILL AND OTHER INTANGIBLE ASSETS - Goodwill (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Mar. 31, 2021	Mar. 31, 2020	Jun. 30, 2020
Changes in goodwill
Goodwill, gross, beginning balance			$ 2,372
Accumulated impairments	$ (1,041)		(1,041)		$ (971)
Goodwill, beginning balance			1,401
Goodwill acquired during the period			10
Goodwill impairment			(67)
Translation adjustments, goodwill			28
Translation adjustments, accumulated impairments			(3)
Goodwill, period increase (decrease)			(32)
Goodwill, gross, ending balance	2,410		2,410
Goodwill, ending balance	1,369		1,369
Restructuring and other charges	131	$ 24	172	$ 54
Goodwill and Other Intangible Assets | BECCA
Changes in goodwill
Restructuring and other charges	13		13
Skin Care
Changes in goodwill
Goodwill, gross, beginning balance			519
Accumulated impairments	(150)		(150)		(95)
Goodwill, beginning balance			424
Goodwill acquired during the period			0
Goodwill impairment			(54)
Translation adjustments, goodwill			21
Translation adjustments, accumulated impairments			(1)
Goodwill, period increase (decrease)			(34)
Goodwill, gross, ending balance	540		540
Goodwill, ending balance	390		390
Makeup
Changes in goodwill
Goodwill, gross, beginning balance			1,210
Accumulated impairments	(830)		(830)		(817)
Goodwill, beginning balance			393
Goodwill acquired during the period			6
Goodwill impairment			(13)
Translation adjustments, goodwill			0
Translation adjustments, accumulated impairments			0
Goodwill, period increase (decrease)			(7)
Goodwill, gross, ending balance	1,216		1,216
Goodwill, ending balance	386		386
Fragrance
Changes in goodwill
Goodwill, gross, beginning balance			254
Accumulated impairments	(26)		(26)		(26)
Goodwill, beginning balance			228
Goodwill acquired during the period			0
Goodwill impairment			0
Translation adjustments, goodwill			4
Translation adjustments, accumulated impairments			0
Goodwill, period increase (decrease)			4
Goodwill, gross, ending balance	258		258
Goodwill, ending balance	232		232
Hair Care
Changes in goodwill
Goodwill, gross, beginning balance			389
Accumulated impairments	(35)		(35)		$ (33)
Goodwill, beginning balance			356
Goodwill acquired during the period			4
Goodwill impairment			0
Translation adjustments, goodwill			3
Translation adjustments, accumulated impairments			(2)
Goodwill, period increase (decrease)			5
Goodwill, gross, ending balance	396		396
Goodwill, ending balance	$ 361		$ 361

GOODWILL AND OTHER INTANGIBLE_4

GOODWILL AND OTHER INTANGIBLE ASSETS - Other Intangible Assets (Details) - USD ($) $ in Millions	Mar. 31, 2021	Jun. 30, 2020
Amortizable intangible assets:
Gross Carrying Value	$ 1,684	$ 1,633
Accumulated Amortization	607	518
Total Net Book Value	1,077	1,115
Non-amortizable intangible assets:
Total intangible assets	2,294	2,338
Estimated aggregate amortization expense
Estimated aggregate amortization expense for remainder of fiscal year 2021	24
Estimated aggregate amortization expense for fiscal year 2022	101
Estimated aggregate amortization expense for fiscal year 2023	100
Estimated aggregate amortization expense for fiscal year 2024	100
Estimated aggregate amortization expense for fiscal year 2025	100
Trademarks and other
Non-amortizable intangible assets:
Trademarks and other	1,217	1,223
Trademarks and other | GLAMGLOW | The Americas | Skin Care
Non-amortizable intangible assets:
Trademarks and other	36
Customer lists and other
Amortizable intangible assets:
Gross Carrying Value	1,641	1,590
Accumulated Amortization	564	475
Total Net Book Value	1,077	1,115
License Agreements
Amortizable intangible assets:
Gross Carrying Value	43	43
Accumulated Amortization	43	43
Total Net Book Value	$ 0	$ 0

GOODWILL AND OTHER INTANGIBLE_5

GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details) - USD ($) $ in Millions	1 Months Ended	3 Months Ended			9 Months Ended
	Nov. 30, 2020	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2019	Mar. 31, 2021	Mar. 31, 2020	Jun. 30, 2020
Goodwill and Other Intangible Assets
Aggregate amortization expense for amortizable intangible assets		$ 25	$ 23		$ 77	$ 45
Goodwill impairment		0	275	$ 511	54	786
Trademarks and other
Goodwill and Other Intangible Assets
Impairment charges of indefinite-lived intangible assets			58	$ 266		324
Carrying value		1,217			1,217		$ 1,223
GLAMGLOW | The Americas | Skin Care
Goodwill and Other Intangible Assets
Goodwill impairment	$ 54		52			52
GLAMGLOW | Trademarks and other | The Americas | Skin Care
Goodwill and Other Intangible Assets
Impairment charges of indefinite-lived intangible assets	21		$ 1			$ 1
Carrying value		$ 36			$ 36
GLAMGLOW | Customer lists | The Americas | Skin Care
Goodwill and Other Intangible Assets
Impairment charges of finite-lived intangible assets	$ 6

GOODWILL AND OTHER INTANGIBLE_6

GOODWILL AND OTHER INTANGIBLE ASSETS - Impairment (Details) - USD ($) $ in Millions	1 Months Ended	3 Months Ended			9 Months Ended
	Nov. 30, 2020	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2019	Mar. 31, 2021	Mar. 31, 2020
Intangible assets
Goodwill impairment		$ 0	$ 275	$ 511	$ 54	$ 786
Goodwill, fair value			103			103
Trademarks and other
Intangible assets
Impairment Charge, Trademark			58	$ 266		324
Trademark, fair value			417			417
Makeup | The Americas | Too Faced
Intangible assets
Goodwill impairment			162			592
Goodwill, fair value			13			13
Makeup | The Americas | BECCA
Intangible assets
Goodwill impairment			35			70
Goodwill, fair value			28			28
Makeup | The Americas | Smashbox
Intangible assets
Goodwill impairment			26			72
Goodwill, fair value			0			0
Makeup | The Americas | Trademarks and other | Too Faced
Intangible assets
Impairment Charge, Trademark			42			253
Trademark, fair value			272			272
Makeup | The Americas | Trademarks and other | BECCA
Intangible assets
Impairment Charge, Trademark			14			47
Trademark, fair value			51			51
Makeup | The Americas | Trademarks and other | Smashbox
Intangible assets
Impairment Charge, Trademark			1			23
Trademark, fair value			32			32
Skin Care | The Americas | GLAMGLOW
Intangible assets
Goodwill impairment	$ 54		52			52
Goodwill, fair value		$ 0	62		$ 0	62
Skin Care | The Americas | Trademarks and other | GLAMGLOW
Intangible assets
Impairment Charge, Trademark	$ 21		1			1
Trademark, fair value			$ 62			$ 62

CHARGES ASSOCIATED WITH RESTR_3

CHARGES ASSOCIATED WITH RESTRUCTURING AND OTHER ACTIVITIES - Charges Associated With Restructuring Activities (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Mar. 31, 2021	Mar. 31, 2020
Restructuring and Other Costs
Restructuring charges	$ 145	$ 25	$ 191	$ 63
Leading Beauty Forward
Restructuring and Other Costs
Restructuring charges	6		6
PCBA Program
Restructuring and Other Costs
Restructuring charges	139		185
Sales Returns (included in Net Sales)
Restructuring and Other Costs
Restructuring charges	10		10
Sales Returns (included in Net Sales) | Leading Beauty Forward
Restructuring and Other Costs
Restructuring charges	0		0
Sales Returns (included in Net Sales) | PCBA Program
Restructuring and Other Costs
Restructuring charges	10		10
Cost of Sales
Restructuring and Other Costs
Restructuring charges	4		9
Cost of Sales | Leading Beauty Forward
Restructuring and Other Costs
Restructuring charges	(1)		4
Cost of Sales | PCBA Program
Restructuring and Other Costs
Restructuring charges	5		5
Restructuring Charges
Restructuring and Other Costs
Restructuring charges	124		160
Restructuring Charges | Leading Beauty Forward
Restructuring and Other Costs
Restructuring charges	3		(7)
Restructuring Charges | PCBA Program
Restructuring and Other Costs
Restructuring charges	121		167
Other Charges
Restructuring and Other Costs
Restructuring charges	7		12
Other Charges | Leading Beauty Forward
Restructuring and Other Costs
Restructuring charges	4		9
Other Charges | PCBA Program
Restructuring and Other Costs
Restructuring charges	$ 3		$ 3

CHARGES ASSOCIATED WITH RESTR_4

CHARGES ASSOCIATED WITH RESTRUCTURING AND OTHER ACTIVITIES - Approved Restructuring Activities by Major Cost Type (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Mar. 31, 2021	Mar. 31, 2020
Restructuring and related costs
Restructuring and other charges	$ 131	$ 24	$ 172	$ 54
Leading Beauty Forward
Restructuring and related costs
Cumulative through June 30, 2020			967
Restructuring and other charges			0
Cumulative through March 31, 2021	967		967
Leading Beauty Forward | Sales Returns (included in Net Sales)
Restructuring and related costs
Cumulative through June 30, 2020			13
Restructuring and other charges			1
Cumulative through March 31, 2021	14		14
Leading Beauty Forward | Cost of Sales
Restructuring and related costs
Cumulative through June 30, 2020			85
Restructuring and other charges			0
Cumulative through March 31, 2021	85		85
Leading Beauty Forward | Restructuring Charges
Restructuring and related costs
Cumulative through June 30, 2020			511
Restructuring and other charges			(11)
Cumulative through March 31, 2021	500		500
Leading Beauty Forward | Restructuring Charges | Employee- Related Costs
Restructuring and related costs
Cumulative through June 30, 2020			460
Restructuring and other charges			(13)
Cumulative through March 31, 2021	447		447
Leading Beauty Forward | Restructuring Charges | Asset- Related Costs
Restructuring and related costs
Cumulative through June 30, 2020			28
Restructuring and other charges			0
Cumulative through March 31, 2021	28		28
Leading Beauty Forward | Restructuring Charges | Contract Terminations
Restructuring and related costs
Cumulative through June 30, 2020			7
Restructuring and other charges			2
Cumulative through March 31, 2021	9		9
Leading Beauty Forward | Restructuring Charges | Other Exit Costs
Restructuring and related costs
Cumulative through June 30, 2020			16
Restructuring and other charges			0
Cumulative through March 31, 2021	16		16
Leading Beauty Forward | Other Charges
Restructuring and related costs
Cumulative through June 30, 2020			358
Restructuring and other charges			10
Cumulative through March 31, 2021	$ 368		368
PCBA Program
Restructuring and related costs
Restructuring and other charges			230
PCBA Program | Sales Returns (included in Net Sales)
Restructuring and related costs
Restructuring and other charges			39
PCBA Program | Cost of Sales
Restructuring and related costs
Restructuring and other charges			(6)
PCBA Program | Restructuring Charges
Restructuring and related costs
Restructuring and other charges			180
PCBA Program | Restructuring Charges | Employee- Related Costs
Restructuring and related costs
Restructuring and other charges			73
PCBA Program | Restructuring Charges | Asset- Related Costs
Restructuring and related costs
Restructuring and other charges			99
PCBA Program | Restructuring Charges | Contract Terminations
Restructuring and related costs
Restructuring and other charges			5
PCBA Program | Restructuring Charges | Other Exit Costs
Restructuring and related costs
Restructuring and other charges			3
PCBA Program | Other Charges
Restructuring and related costs
Restructuring and other charges			$ 17

CHARGES ASSOCIATED WITH RESTR_5

CHARGES ASSOCIATED WITH RESTRUCTURING AND OTHER ACTIVITIES - Cumulative Restructuring Charges by Major Cost Type (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Mar. 31, 2021	Mar. 31, 2020
Restructuring and related costs
Charges (adjustments)	$ 145	$ 25	$ 191	$ 63
Restructuring and other charges	131	$ 24	172	$ 54
Goodwill and Other Intangible Assets | BECCA
Restructuring and related costs
Restructuring and other charges	13		13
Other intangible asset charges	34		34
Sales Returns (included in Net Sales)
Restructuring and related costs
Charges (adjustments)	10		10
Cost of Sales
Restructuring and related costs
Charges (adjustments)	4		9
Restructuring Charges
Restructuring and related costs
Charges (adjustments)	124		160
Other Charges
Restructuring and related costs
Charges (adjustments)	7		12
Leading Beauty Forward
Restructuring and related costs
Cumulative through June 30, 2020			874
Charges (adjustments)	6		6
Cumulative through March 31, 2021	880		880
Restructuring and other charges			0
Leading Beauty Forward | Sales Returns (included in Net Sales)
Restructuring and related costs
Cumulative through June 30, 2020			14
Charges (adjustments)	0		0
Cumulative through March 31, 2021	14		14
Restructuring and other charges			1
Leading Beauty Forward | Cost of Sales
Restructuring and related costs
Cumulative through June 30, 2020			65
Charges (adjustments)	(1)		4
Cumulative through March 31, 2021	69		69
Restructuring and other charges			0
Leading Beauty Forward | Restructuring Charges
Restructuring and related costs
Cumulative through June 30, 2020			491
Charges (adjustments)	3		(7)
Cumulative through March 31, 2021	484		484
Restructuring and other charges			(11)
Leading Beauty Forward | Restructuring Charges | Employee- Related Costs
Restructuring and related costs
Cumulative through June 30, 2020			451
Charges (adjustments)			(10)
Cumulative through March 31, 2021	441		441
Restructuring and other charges			(13)
Leading Beauty Forward | Restructuring Charges | Asset- Related Costs
Restructuring and related costs
Cumulative through June 30, 2020			27
Charges (adjustments)			0
Cumulative through March 31, 2021	27		27
Restructuring and other charges			0
Leading Beauty Forward | Restructuring Charges | Contract Terminations
Restructuring and related costs
Cumulative through June 30, 2020			6
Charges (adjustments)			1
Cumulative through March 31, 2021	7		7
Restructuring and other charges			2
Leading Beauty Forward | Restructuring Charges | Other Exit Costs
Restructuring and related costs
Cumulative through June 30, 2020			7
Charges (adjustments)			2
Cumulative through March 31, 2021	9		9
Restructuring and other charges			0
Leading Beauty Forward | Other Charges
Restructuring and related costs
Cumulative through June 30, 2020			304
Charges (adjustments)	4		9
Cumulative through March 31, 2021	313		313
Restructuring and other charges			10
PCBA Program
Restructuring and related costs
Charges (adjustments)	139		185
Cumulative through March 31, 2021	185		185
Restructuring and other charges			230
PCBA Program | Sales Returns (included in Net Sales)
Restructuring and related costs
Charges (adjustments)	10		10
Cumulative through March 31, 2021	10		10
Restructuring and other charges			39
PCBA Program | Cost of Sales
Restructuring and related costs
Charges (adjustments)	5		5
Cumulative through March 31, 2021	5		5
Restructuring and other charges			(6)
PCBA Program | Restructuring Charges
Restructuring and related costs
Charges (adjustments)	121		167
Cumulative through March 31, 2021	167		167
Restructuring and other charges			180
PCBA Program | Restructuring Charges | Employee- Related Costs
Restructuring and related costs
Charges (adjustments)			70
Cumulative through March 31, 2021	70		70
Restructuring and other charges			73
PCBA Program | Restructuring Charges | Asset- Related Costs
Restructuring and related costs
Charges (adjustments)			93
Cumulative through March 31, 2021	93		93
Restructuring and other charges			99
PCBA Program | Restructuring Charges | Contract Terminations
Restructuring and related costs
Charges (adjustments)			4
Cumulative through March 31, 2021	4		4
Restructuring and other charges			5
PCBA Program | Restructuring Charges | Other Exit Costs
Restructuring and related costs
Charges (adjustments)			0
Cumulative through March 31, 2021	0		0
Restructuring and other charges			3
PCBA Program | Other Charges
Restructuring and related costs
Charges (adjustments)	3		3
Cumulative through March 31, 2021	$ 3		3
Restructuring and other charges			$ 17

CHARGES ASSOCIATED WITH RESTR_6

CHARGES ASSOCIATED WITH RESTRUCTURING AND OTHER ACTIVITIES - Accrued Restructuring Charges (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended		12 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Mar. 31, 2021	Mar. 31, 2020	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2021
Restructuring Reserve [Roll Forward]
Charges (adjustments)	$ 145	$ 25	$ 191	$ 63
Restructuring Charges
Restructuring Reserve [Roll Forward]
Charges (adjustments)	124		160
Leading Beauty Forward
Restructuring Reserve [Roll Forward]
Charges (adjustments)	6		6
Leading Beauty Forward | Restructuring Charges
Restructuring Reserve [Roll Forward]
Beginning balance			112				$ 112
Charges (adjustments)	3		(7)
Cash payments			(51)
Translation adjustments			1
Ending balance	55		55
PCBA Program
Restructuring Reserve [Roll Forward]
Charges (adjustments)	139		185
PCBA Program | Restructuring Charges
Restructuring Reserve [Roll Forward]
Charges (adjustments)	121		167
Cash payments			(12)
Noncash asset write-offs			(93)
Ending balance	62		62
Employee- Related Costs | Leading Beauty Forward | Restructuring Charges
Restructuring Reserve [Roll Forward]
Beginning balance			112				112
Charges (adjustments)			(10)
Cash payments			(50)
Translation adjustments			1
Ending balance	53		53
Employee- Related Costs | PCBA Program | Restructuring Charges
Restructuring Reserve [Roll Forward]
Charges (adjustments)			70
Cash payments			(8)
Noncash asset write-offs			0
Ending balance	62		62
Asset- Related Costs | Leading Beauty Forward | Restructuring Charges
Restructuring Reserve [Roll Forward]
Beginning balance			0				0
Charges (adjustments)			0
Cash payments			0
Translation adjustments			0
Ending balance	0		0
Asset- Related Costs | PCBA Program | Restructuring Charges
Restructuring Reserve [Roll Forward]
Charges (adjustments)			93
Cash payments			0
Noncash asset write-offs			(93)
Ending balance	0		0
Contract Terminations | Leading Beauty Forward | Restructuring Charges
Restructuring Reserve [Roll Forward]
Beginning balance			0				0
Charges (adjustments)			1
Cash payments			(1)
Translation adjustments			0
Ending balance	0		0
Contract Terminations | PCBA Program | Restructuring Charges
Restructuring Reserve [Roll Forward]
Charges (adjustments)			4
Cash payments			(4)
Noncash asset write-offs			0
Ending balance	0		0
Other Exit Costs | Leading Beauty Forward | Restructuring Charges
Restructuring Reserve [Roll Forward]
Beginning balance			0				0
Charges (adjustments)			2
Cash payments			0
Translation adjustments			0
Ending balance	2		2
Other Exit Costs | PCBA Program | Restructuring Charges
Restructuring Reserve [Roll Forward]
Charges (adjustments)			0
Cash payments			0
Noncash asset write-offs			0
Ending balance	$ 0		$ 0
Forecast | Leading Beauty Forward
Restructuring Reserve [Roll Forward]
Accrued restructuring charges expected to result in cash expenditures funded from cash provided by operations					$ 4	$ 14	37
Forecast | PCBA Program
Restructuring Reserve [Roll Forward]
Accrued restructuring charges expected to result in cash expenditures funded from cash provided by operations					$ 7	$ 18	$ 37

CHARGES ASSOCIATED WITH RESTR_7

CHARGES ASSOCIATED WITH RESTRUCTURING AND OTHER ACTIVITIES - Narrative (Details) - PCBA Program $ in Millions	Aug. 20, 2020USD ($)position
Restructuring and Other Costs
Restructuring program, period	2 years
Minimum
Restructuring and Other Costs
Net reduction in global positions | position	1,500
Closure of freestanding stores (as a percent)	10.00%
Restructuring and related costs, expected costs | $	$ 400
Maximum
Restructuring and Other Costs
Net reduction in global positions | position	2,000
Closure of freestanding stores (as a percent)	15.00%
Restructuring and related costs, expected costs | $	$ 500

DEBT - Narrative (Details)

DEBT - Narrative (Details) - USD ($)	1 Months Ended
	Aug. 31, 2020	Mar. 31, 2021	Jun. 30, 2020
Revolving Credit Facility Expiring October2023
Debt
Repayments of lines of credit	$ 750,000,000
Line of credit facility, maximum borrowing capacity			$ 1,500,000,000
1.950% Senior Notes due March 15, 2031 ("2031 Senior Notes")
Debt
Aggregate principal amount		$ 600,000,000
Interest rate, stated percentage		1.95%
1.70% Senior Notes, due May 10, 2021 ("2021 Senior Notes")
Debt
Interest rate, stated percentage		1.70%

DEBT - Schedule of Long-Term De

DEBT - Schedule of Long-Term Debt (Details) - USD ($)	1 Months Ended	3 Months Ended		9 Months Ended
	Mar. 31, 2020	Mar. 31, 2021	Mar. 31, 2020	Mar. 31, 2021	Mar. 31, 2020
Debt
Gain (loss) on derivative instruments recognized in other comprehensive income		$ 158,000,000	$ 24,000,000	$ (46,000,000)	$ (15,000,000)
1.950% Senior Notes due March 15, 2031 ("2031 Senior Notes")
Debt
Price (as a percent)		99.34%		99.34%
Yield (as a percent)		2.023%		2.023%
Unamortized Debt Discount		$ (4,000,000)		$ (4,000,000)
Debt Issuance Costs		$ (4,000,000)		$ (4,000,000)
1.950% Senior Notes due March 15, 2031 ("2031 Senior Notes") | Treasury lock agreements
Debt
Yield (as a percent)	1.89%		1.89%		1.89%
Notional amount	$ 200,000,000		$ 200,000,000		$ 200,000,000
Weighted-average all-in rate (as a percent)	0.84%		0.84%		0.84%
Gain (loss) on derivative instruments recognized in other comprehensive income	$ 11,000,000

DERIVATIVE FINANCIAL INSTRUME_3

DERIVATIVE FINANCIAL INSTRUMENTS - Derivative Instruments Included in the Consolidated Balance Sheets (Details) - USD ($) $ in Millions	Mar. 31, 2021	Jun. 30, 2020
Derivatives, Fair Value
Derivative asset, total	$ 143	$ 102
Derivative liability, total	144	83
Derivatives Designated as Hedging Instruments | Prepaid expenses and other current assets
Derivatives, Fair Value
Derivative asset, fair value	138	62
Derivatives Designated as Hedging Instruments | Other accrued liabilities
Derivatives, Fair Value
Derivative liability, fair value	36	68
Derivatives Designated as Hedging Instruments | Foreign currency cash flow hedges | Prepaid expenses and other current assets
Derivatives, Fair Value
Derivative asset, fair value	16	26
Derivatives Designated as Hedging Instruments | Foreign currency cash flow hedges | Other accrued liabilities
Derivatives, Fair Value
Derivative liability, fair value	21	3
Derivatives Designated as Hedging Instruments | Net investment hedges | Prepaid expenses and other current assets
Derivatives, Fair Value
Derivative asset, fair value	115	21
Derivatives Designated as Hedging Instruments | Net investment hedges | Other accrued liabilities
Derivatives, Fair Value
Derivative liability, fair value	0	62
Derivatives Designated as Hedging Instruments | Interest rate-related derivatives | Prepaid expenses and other current assets
Derivatives, Fair Value
Derivative asset, fair value	7	15
Derivatives Designated as Hedging Instruments | Interest rate-related derivatives | Other accrued liabilities
Derivatives, Fair Value
Derivative liability, fair value	15	3
Derivatives Not Designated as Hedging Instruments | Foreign currency forward contracts | Prepaid expenses and other current assets
Derivatives, Fair Value
Derivative asset, fair value	5	40
Derivatives Not Designated as Hedging Instruments | Foreign currency forward contracts | Other accrued liabilities
Derivatives, Fair Value
Derivative liability, fair value	$ 108	$ 15

DERIVATIVE FINANCIAL INSTRUME_4

DERIVATIVE FINANCIAL INSTRUMENTS - Gain (Loss) on Derivative Financial Instruments (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Mar. 31, 2021	Mar. 31, 2020
Gain (loss) on derivative financial instruments
Amount of Gain or (Loss) Recognized in OCI on Derivatives, Cash Flow Hedging	$ 158	$ 24	$ (46)	$ (15)
Amounts reclassified to earnings during the year	(8)	10	(13)	29
Cash flow hedges
Gain (loss) on derivative financial instruments
Amount of Gain or (Loss) Recognized in OCI on Derivatives, Cash Flow Hedging	33	44	(29)	39
Amounts reclassified to earnings during the year	(8)	10	(13)	29
Current debt
Gain (loss) on derivative financial instruments
Cumulative Amount of Fair Value Hedging Gain (Loss) Included in the Carrying Amount of the Hedged Liability			1
Current debt | Derivatives in fair value hedging relationships
Gain (loss) on derivative financial instruments
Carrying Amount of the Hedged Liabilities	451		451
Long-term debt
Gain (loss) on derivative financial instruments
Cumulative Amount of Fair Value Hedging Gain (Loss) Included in the Carrying Amount of the Hedged Liability			(9)
Long-term debt | Derivatives in fair value hedging relationships
Gain (loss) on derivative financial instruments
Carrying Amount of the Hedged Liabilities	936		936
Total debt
Gain (loss) on derivative financial instruments
Cumulative Amount of Fair Value Hedging Gain (Loss) Included in the Carrying Amount of the Hedged Liability			(8)
Total debt | Derivatives in fair value hedging relationships
Gain (loss) on derivative financial instruments
Carrying Amount of the Hedged Liabilities	1,387		1,387
Net sales
Gain (loss) on derivative financial instruments
Total amounts of income and expense line items presented in the consolidated statements of earnings (loss) in which the effects of fair value and cash flow hedges are recorded	3,864	3,345	12,279	11,864
Interest expense
Gain (loss) on derivative financial instruments
Total amounts of income and expense line items presented in the consolidated statements of earnings (loss) in which the effects of fair value and cash flow hedges are recorded	43	42	131	112
Foreign currency forward contracts | Cash flow hedges
Gain (loss) on derivative financial instruments
Amount of Gain or (Loss) Recognized in OCI on Derivatives, Cash Flow Hedging	22	46	(43)	50
Foreign currency forward contracts | Net investment hedges
Gain (loss) on derivative financial instruments
Amount of Gain or (Loss) Recognized in OCI on Derivatives, Cash Flow Hedging	125	(20)	(17)	(54)
Amounts reclassified to earnings during the year	0	0	0	0
Foreign currency forward contracts | Net sales | Cash flow hedges
Gain (loss) on derivative financial instruments
Amounts reclassified to earnings during the year	(7)	10	(11)	29
Interest rate-related derivatives | Cash flow hedges
Gain (loss) on derivative financial instruments
Amount of Gain or (Loss) Recognized in OCI on Derivatives, Cash Flow Hedging	11	(2)	14	(11)
Interest rate-related derivatives | Interest expense | Cash flow hedges
Gain (loss) on derivative financial instruments
Amounts reclassified to earnings during the year	(1)	0	(2)	0
Interest rate-related derivatives | Interest expense | Derivatives in fair value hedging relationships
Gain (loss) on derivative financial instruments
Amount of gain (loss) reclassified from AOCI to earnings	18	(12)	23	(13)
Net investment hedges
Gain (loss) on derivative financial instruments
Gain recognized in earnings related to the amount excluded from effectiveness testing	5	12	15	37
Derivatives Designated as Hedging Instruments | Interest rate-related derivatives | Interest expense | Derivatives in fair value hedging relationships
Gain (loss) on derivative financial instruments
Amount of gain (loss) reclassified from AOCI to earnings	(18)	12	(23)	13
Amount of gain (loss) reclassified from AOCI to earnings	(18)	12	(23)	13
Derivatives Not Designated as Hedging Instruments | Foreign currency forward contracts | Selling, general and administrative
Gain (loss) on derivative financial instruments
Amount of gain (loss) reclassified from AOCI to earnings	$ (97)	$ 49	$ (34)	$ 52

DERIVATIVE FINANCIAL INSTRUME_5

DERIVATIVE FINANCIAL INSTRUMENTS - Cash Flow Hedges, Fair Value Hedges, Credit Risk (Details)	Mar. 31, 2021USD ($)agency	Jun. 30, 2020USD ($)
Derivatives Not Designated as Hedging Instruments
Derivative instruments
Notional amount	$ 4,404,000,000
Foreign Currency Cash-Flow Hedges
Notional amount	$ 4,404,000,000
Derivative
Credit Risk
Minimum number of nationally recognized rating agencies | agency	2
Maximum exposure to credit risk in the event of non performance by counterparties, gross fair value of contracts in asset positions	$ 143,000,000
Cash flow hedges
Foreign Currency Cash-Flow Hedges
Amount expected to be reclassified from AOCI into earnings, net of tax, within the next twelve months	8,000,000
Accumulated net gain on derivative instruments in AOCI, before tax	4,000,000	$ 20,000,000
Cash flow hedges | Foreign currency forward contracts
Derivative instruments
Notional amount	1,390,000,000
Foreign Currency Cash-Flow Hedges
Notional amount	1,390,000,000
Derivatives in fair value hedging relationships | Interest rate swap contracts | 1.70% Senior Notes, due May 10, 2021 ("2021 Senior Notes")
Fair Value Hedges
Notional amount	450,000,000
Derivatives in fair value hedging relationships | Interest rate swap contracts | 2.35% Senior Notes due August 15, 2022 ("2022 Senior Notes")
Fair Value Hedges
Notional amount	250,000,000
Derivatives in fair value hedging relationships | Interest rate swap contracts | 2.600% Senior Notes due April 15, 2030 (the "2030 Senior Notes")
Fair Value Hedges
Notional amount	700,000,000
Net investment hedges | Foreign currency forward contracts
Fair Value Hedges
Notional amount	$ 1,920,000,000

FAIR VALUE MEASUREMENTS - Hiera

FAIR VALUE MEASUREMENTS - Hierarchy For Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - Recurring basis - USD ($) $ in Millions	Mar. 31, 2021	Jun. 30, 2020
Assets:
Foreign currency forward contracts	$ 136	$ 87
Interest rate-related derivatives	7	15
Total	3,661	2,912
Liabilities:
Foreign currency forward contracts	129	80
Interest rate-related derivatives	15	3
Contingent consideration	2	4
Total	146	87
Money market funds
Assets:
Money market funds	3,518	2,810
Level 1
Assets:
Foreign currency forward contracts	0	0
Interest rate-related derivatives	0	0
Total	3,518	2,810
Liabilities:
Foreign currency forward contracts	0	0
Interest rate-related derivatives	0	0
Contingent consideration	0	0
Total	0	0
Level 1 | Money market funds
Assets:
Money market funds	3,518	2,810
Level 2
Assets:
Foreign currency forward contracts	136	87
Interest rate-related derivatives	7	15
Total	143	102
Liabilities:
Foreign currency forward contracts	129	80
Interest rate-related derivatives	15	3
Contingent consideration	0	0
Total	144	83
Level 2 | Money market funds
Assets:
Money market funds	0	0
Level 3
Assets:
Foreign currency forward contracts	0	0
Interest rate-related derivatives	0	0
Total	0	0
Liabilities:
Foreign currency forward contracts	0	0
Interest rate-related derivatives	0	0
Contingent consideration	2	4
Total	2	4
Level 3 | Money market funds
Assets:
Money market funds	$ 0	$ 0

FAIR VALUE MEASUREMENTS - Estim

FAIR VALUE MEASUREMENTS - Estimated Fair Values of Financial Instruments (Details) - USD ($) $ in Millions	Mar. 31, 2021	Jun. 30, 2020
Derivatives
Derivative asset	$ 143	$ 102
Derivative liability	(144)	(83)
Carrying Amount
Nonderivatives
Cash and cash equivalents	6,399	5,022
Current and long-term debt	5,958	6,136
Contingent consideration	2	4
Carrying Amount | Foreign currency forward contracts
Derivatives
Derivative asset	7	7
Carrying Amount | Interest rate-related derivatives
Derivatives
Derivative asset		12
Derivative liability	(8)
Fair Value
Nonderivatives
Cash and cash equivalents	6,399	5,022
Current and long-term debt	6,465	6,902
Contingent consideration	2	4
Fair Value | Foreign currency forward contracts
Derivatives
Derivative asset	7	7
Fair Value | Interest rate-related derivatives
Derivatives
Derivative asset		$ 12
Derivative liability	$ (8)

FAIR VALUE MEASUREMENTS - Impai

FAIR VALUE MEASUREMENTS - Impairment Charges (Details) - USD ($) $ in Millions	3 Months Ended			9 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2019	Mar. 31, 2021	Mar. 31, 2020
Estimated fair values of financial instruments
Goodwill impairment	$ 0	$ 275	$ 511	$ 54	$ 786
Goodwill, fair value		103			103
Trademarks and other
Estimated fair values of financial instruments
Impairment Charge, Trademark		58	$ 266		324
Trademark, fair value		417			417
Level 3 | Fair Value, Nonrecurring
Estimated fair values of financial instruments
Goodwill impairment				67	786
Long-lived assets, impairment charge				33	13
Impairment charges				161	1,123
Level 3 | Fair Value, Nonrecurring | GLAMGLOW
Estimated fair values of financial instruments
Goodwill impairment				54
Level 3 | Fair Value, Nonrecurring | BECCA
Estimated fair values of financial instruments
Goodwill impairment				13
Level 3 | Fair Value, Nonrecurring | Trademarks and Customer Lists
Estimated fair values of financial instruments
Impairment Charge, Trademark				61
Level 3 | Fair Value, Nonrecurring | Trademarks and Customer Lists | GLAMGLOW
Estimated fair values of financial instruments
Impairment Charge, Trademark				27
Level 3 | Fair Value, Nonrecurring | Trademarks and Customer Lists | BECCA
Estimated fair values of financial instruments
Impairment Charge, Trademark				34
Level 3 | Fair Value, Nonrecurring | Trademarks and other
Estimated fair values of financial instruments
Impairment Charge, Trademark					324
Level 3 | Fair Value, Nonrecurring | Fair Value
Estimated fair values of financial instruments
Goodwill, fair value	0	103		0	103
Long-lived assets, fair value	35	11		35	11
Fair Value	71	531		71	531
Level 3 | Fair Value, Nonrecurring | Fair Value | GLAMGLOW
Estimated fair values of financial instruments
Goodwill, fair value	0			0
Level 3 | Fair Value, Nonrecurring | Fair Value | BECCA
Estimated fair values of financial instruments
Goodwill, fair value	0			0
Level 3 | Fair Value, Nonrecurring | Fair Value | Trademarks and Customer Lists
Estimated fair values of financial instruments
Trademark, fair value	36			36
Level 3 | Fair Value, Nonrecurring | Fair Value | Trademarks and Customer Lists | GLAMGLOW
Estimated fair values of financial instruments
Trademark, fair value	36			36
Level 3 | Fair Value, Nonrecurring | Fair Value | Trademarks and Customer Lists | BECCA
Estimated fair values of financial instruments
Trademark, fair value	$ 0			$ 0
Level 3 | Fair Value, Nonrecurring | Fair Value | Trademarks and other
Estimated fair values of financial instruments
Trademark, fair value		$ 417			$ 417

FAIR VALUE MEASUREMENTS - Forei

FAIR VALUE MEASUREMENTS - Foreign Currency Forward Contracts Maturity and Additional Purchase Price Payable - Narrative (Details) - Foreign currency forward contracts	9 Months Ended
	Mar. 31, 2021
Maximum | LIBOR
Foreign currency forward contracts
Contract maturities	12 months
Minimum | Swap yield curve
Foreign currency forward contracts
Contract maturities	12 months

FAIR VALUE MEASUREMENTS - Conti

FAIR VALUE MEASUREMENTS - Contingent Consideration Roll forward (Details) - USD ($) $ in Millions	9 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Business Combination, Contingent Consideration [Roll Forward]
Changes in fair value of contingent consideration	$ (2)	$ (9)
Selling, general and administrative expenses
Business Combination, Contingent Consideration [Roll Forward]
Contingent consideration at June 30, 2020	4
Changes in fair value of contingent consideration	(2)
Contingent consideration at March 31, 2021	$ 2

REVENUE RECOGNITION - Narrative

REVENUE RECOGNITION - Narrative (Details) - USD ($) $ in Millions	Mar. 31, 2021	Dec. 31, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Jun. 30, 2019
REVENUE RECOGNITION
Allowance for doubtful accounts and customer deductions	$ 50		$ 63
Adjustment to retained earnings	5,558		3,962	$ 4,358
Allowance for non-credit losses	25
Retained Earnings
REVENUE RECOGNITION
Adjustment to retained earnings	$ 11,420	$ 11,159	10,134	$ 10,595	$ 10,775	$ 9,984
Cumulative Effect, Period of Adoption, Adjustment | Retained Earnings
REVENUE RECOGNITION
Adjustment to retained earnings		$ 0	(3)		$ 0	$ (29)
Cumulative Effect, Period of Adoption, Adjustment | Retained Earnings | Accounting Standards Update 2016-13
REVENUE RECOGNITION
Adjustment to retained earnings			$ (3)

REVENUE RECOGNITION - Changes i

REVENUE RECOGNITION - Changes in Allowance for Credit Losses (Details) $ in Millions	9 Months Ended
	Mar. 31, 2021USD ($)
Accounts Receivable, Allowance for Credit Loss [Roll Forward]
Balance at June 30, 2020	$ 36
Adjustment for expected credit losses	(5)
Write-offs, net & other	(10)
Balance at March 31, 2021	25
Cumulative Effect, Period of Adoption, Adjustment
Accounts Receivable, Allowance for Credit Loss [Roll Forward]
Balance at June 30, 2020	$ 4

REVENUE RECOGNITION - Changes_2

REVENUE RECOGNITION - Changes in Deferred Revenue (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Mar. 31, 2021	Mar. 31, 2020
Change in Contract with Customer, Liability [Abstract]
Balance at the beginning of the period	$ 420	$ 425	$ 279	$ 361
Revenue recognized that was included in the deferred revenue balance at the beginning of the period	(25)	(26)	(198)	(268)
Revenue deferred (released) during the period	(30)	(37)	278	269
Other	(4)	0	2	0
Balance at the end of the period	$ 361	$ 362	$ 361	$ 362

REVENUE RECOGNITION - Transacti

REVENUE RECOGNITION - Transaction Price Allocated to the Remaining Performance Obligations (Details) - Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-04-01 $ in Millions	Mar. 31, 2021USD ($)
REVENUE RECOGNITION
Expected timing of revenue recognition	12 months
Estimated recognition of deferred revenue	$ 310

PENSION AND POST-RETIREMENT B_3

PENSION AND POST-RETIREMENT BENEFIT PLANS - Components of Net Periodic Benefit Cost (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Mar. 31, 2021	Mar. 31, 2020
Pension Plans | U.S.
Components of net periodic benefit cost:
Service cost	$ 12	$ 9	$ 34	$ 29
Interest cost	8	9	23	26
Expected return on plan assets	(14)	(14)	(40)	(40)
Amortization of:
Actuarial loss	5	5	15	12
Settlements	0	0	0	0
Special termination benefits	0	0	0	0
Net periodic benefit cost	11	9	32	27
Pension Plans | International
Components of net periodic benefit cost:
Service cost	9	9	27	27
Interest cost	2	3	7	8
Expected return on plan assets	(4)	(4)	(10)	(11)
Amortization of:
Actuarial loss	1	1	3	4
Settlements	1	0	1	0
Special termination benefits	1	1	10	1
Net periodic benefit cost	10	10	38	29
Employer contributions			22
Other than Pension Plans Post-retirement
Components of net periodic benefit cost:
Service cost	2	0	2	2
Interest cost	1	2	4	5
Expected return on plan assets	(1)	0	(1)	(1)
Amortization of:
Actuarial loss	0	0	0	0
Settlements	0	0	0	0
Special termination benefits	0	0	0	0
Net periodic benefit cost	$ 2	$ 2	$ 5	$ 6

PENSION AND POST-RETIREMENT B_4

PENSION AND POST-RETIREMENT BENEFIT PLANS - Amounts Recognized in the Consolidated Balance Sheets (Details) - USD ($) $ in Millions	Mar. 31, 2021	Jun. 30, 2020
Amounts recognized in the consolidated balance sheets consist of:
Other assets	$ 137	$ 127
Other accrued liabilities	(27)	(27)
Other noncurrent liabilities	(470)	(440)
Funded status	(360)	(340)
Accumulated other comprehensive loss	304	324
Net amount recognized	$ (56)	$ (16)

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details) - DECIEM - USD ($) $ in Millions	1 Months Ended
	May 31, 2021	Feb. 28, 2021
Noncontrolling Interest [Line Items]
Equity interest (as a percent)		29.00%
Subsequent Event | Forecast
Noncontrolling Interest [Line Items]
Equity interest (as a percent)	76.00%
Payments to acquire additional equity interests	$ 1,000
Period to sell remaining interests	3 years

STOCK PROGRAMS - Compensation E

STOCK PROGRAMS - Compensation Expense and Stock Options (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Mar. 31, 2021	Mar. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award
Non-cash stock-based compensation	$ 86	$ 71	$ 255	$ 210
Stock Options | Common Class A
Share-based Compensation Arrangement by Share-based Payment Award
Grant at fair value (in shares)			1.5
Exercise price (in dollars per share)			$ 218.40
Weighted-average grant date fair value (in dollars per share)			$ 54.61
Additional General Disclosures
Intrinsic value of stock options exercised (in dollars)			$ 317

STOCK PROGRAMS - Restricted Sto

STOCK PROGRAMS - Restricted Stock Units (Details) - Restricted Stock Units - Employee - Common Class A shares in Millions	9 Months Ended
	Mar. 31, 2021$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award
Granted (in shares)	1
Weighted-average grant date fair value (in dollars per share) | $ / shares	$ 219.01
RSU grants scheduled to vest in fiscal 2022
Share-based Compensation Arrangement by Share-based Payment Award
RSU grants scheduled to vest (in shares)	0.3
RSU grants scheduled to vest in fiscal 2023
Share-based Compensation Arrangement by Share-based Payment Award
RSU grants scheduled to vest (in shares)	0.4
RSU grants scheduled to vest in fiscal 2024
Share-based Compensation Arrangement by Share-based Payment Award
RSU grants scheduled to vest (in shares)	0.3

STOCK PROGRAMS - Performance Sh

STOCK PROGRAMS - Performance Share Units (Details) - Performance Share Units - Employee - $ / shares shares in Millions	1 Months Ended	9 Months Ended	12 Months Ended
	Sep. 30, 2020	Mar. 31, 2021	Jun. 30, 2020
Share-based Compensation Arrangement by Share-based Payment Award
Vested (in shares)			0.5
Common Class A
Share-based Compensation Arrangement by Share-based Payment Award
Granted (in shares)		0.1
Weighted-average grant date fair value (in dollars per share)		$ 218.11
Common Stock issued (in shares)	0.2

STOCK PROGRAMS - Long-term Perf

STOCK PROGRAMS - Long-term Performance Share Units (Details) - Executive Officer - Long Term Performance Shares - Employee - Common Class A $ in Millions	1 Months Ended
	Mar. 31, 2021USD ($)shares
Share-based Compensation Arrangement by Share-based Payment Award
Payout for performance share units in Class A Common Stock (in shares) | shares	68,578
Grant date fair value	$ 20
Unrecognized compensation cost	$ 20
Recognition period	3 years 3 months 18 days

STOCK PROGRAMS - Long-term Pric

STOCK PROGRAMS - Long-term Price Vested Units (Details) - Long-Term Price-Vested Units - Employee - Common Class A - Executive Officer $ in Millions	1 Months Ended
	Mar. 31, 2021USD ($)shares
Share-based Compensation Arrangement by Share-based Payment Award
Payout for performance share units in Class A Common Stock (in shares) | shares	85,927
Consecutive trading days	20 days
Grant date fair value	$ 20
Unrecognized compensation cost	$ 20
Recognition period	3 years 3 months 18 days

STOCK PROGRAMS - Schedule of Lo

STOCK PROGRAMS - Schedule of Long-term Price Vested Units (Details) - Long-Term Price-Vested Units - Executive Officer - Employee - Common Class A	1 Months Ended
	Mar. 31, 2021$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award
Number of Shares per Tranche	85,927
First tranche
Share-based Compensation Arrangement by Share-based Payment Award
Number of Shares per Tranche	27,457
Stock Price Goal (per Share) | $ / shares	$ 323.03
Second tranche
Share-based Compensation Arrangement by Share-based Payment Award
Number of Shares per Tranche	28,598
Stock Price Goal (per Share) | $ / shares	$ 333.21
Third tranche
Share-based Compensation Arrangement by Share-based Payment Award
Number of Shares per Tranche	29,872
Stock Price Goal (per Share) | $ / shares	$ 343.61

STOCK PROGRAMS - Schedule of As

STOCK PROGRAMS - Schedule of Assumptions Used for Award (Details) - Long-Term Price-Vested Units	9 Months Ended
	Mar. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award
Expected volatility	31.80%
Dividend yield	0.80%
Risk-free interest rate	0.40%
Expected term	3 years 3 months 18 days

NET EARNINGS (LOSS) ATTRIBUTA_3

NET EARNINGS (LOSS) ATTRIBUTABLE TO THE ESTEE LAUDER COMPANIES INC. PER COMMON SHARE - Reconciliation Between Numerator and Denominator of Basic and Diluted EPS Computations (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Mar. 31, 2021	Mar. 31, 2020
Numerator:
Net earnings (loss) attributable to The Estée Lauder Companies Inc.	$ 456	$ (6)	$ 1,852	$ 1,146
Denominator:
Weighted-average common shares outstanding - Basic (in shares)	363.6	360.2	362.9	360.6
Weighted-average common shares outstanding - Diluted (in shares)	369	360.2	368.1	367.1
Net earnings (loss) attributable to The Estée Lauder Companies Inc. per common share:
Basic (in dollars per share)	$ 1.25	$ (0.02)	$ 5.10	$ 3.18
Diluted (in dollars per share)	$ 1.24	$ (0.02)	$ 5.03	$ 3.12
Stock Options
Denominator:
Incremental common shares attributable to share-based payment arrangements (in shares)	4.1	0	3.9	4.6
Performance Share Units
Denominator:
Incremental common shares attributable to share-based payment arrangements (in shares)	0.2	0	0.2	0.3
Restricted Stock Units
Denominator:
Incremental common shares attributable to share-based payment arrangements (in shares)	1.1	0	1.1	1.6

NET EARNINGS (LOSS) ATTRIBUTA_4

NET EARNINGS (LOSS) ATTRIBUTABLE TO THE ESTEE LAUDER COMPANIES INC. PER COMMON SHARE - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares shares in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Mar. 31, 2021	Mar. 31, 2020
Stock Options
Antidilutive Securities Excluded from Computation of Earnings, Per Share
Antidilutive shares excluded from the calculation of diluted earnings per share	0	0	0.9	1.3
Restricted Stock Units and Performance Shares
Antidilutive Securities Excluded from Computation of Earnings, Per Share
Antidilutive shares excluded from the calculation of diluted earnings per share	0	0	0.1	0

NET EARNINGS (LOSS) ATTRIBUTA_5

NET EARNINGS (LOSS) ATTRIBUTABLE TO THE ESTEE LAUDER COMPANIES INC. PER COMMON SHARE - Antidilutive Securities Excluded from Computation of Earnings (Loss) Per Share (Details) - shares shares in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Performance Share Units
Antidilutive Securities Excluded from Computation of Earnings, Per Share
Antidilutive shares excluded from the calculation of diluted earnings per share	0.9	1.2

EQUITY - Equity Roll forward (D

EQUITY - Equity Roll forward (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Mar. 31, 2021	Mar. 31, 2020
Increase (Decrease) in Stockholders' Equity
Beginning of the period			$ 3,962
Net earnings (loss) attributable to The Estée Lauder Companies Inc.	$ 456	$ (6)	1,852	$ 1,146
Other comprehensive income (loss)	(105)	(143)	179	(150)
Net earnings attributable to noncontrolling interests	(2)	(2)	(8)	(9)
End of the period	$ 5,558	$ 4,358	$ 5,558	$ 4,358
Cash dividends declared per common share	$ 0.53	$ 0.48	$ 1.54	$ 1.39
Total Stockholders' equity - The Estee Lauder Companies Inc.
Increase (Decrease) in Stockholders' Equity
End of the period	$ 5,528	$ 4,329	$ 5,528	$ 4,329
Common Stock
Increase (Decrease) in Stockholders' Equity
Beginning of the period	6	6	6	6
Stock-based compensation	0	0	0	0
End of the period	6	6	6	6
Paid-in Capital
Increase (Decrease) in Stockholders' Equity
Beginning of the period	5,068	4,615	4,790	4,403
Stock-based compensation	162	144	439	354
Common stock dividends	1	1	2	3
End of the period	5,231	4,760	5,231	4,760
Retained Earnings
Increase (Decrease) in Stockholders' Equity
Beginning of the period	11,159	10,775	10,134	9,984
Common stock dividends	(195)	(174)	(563)	(506)
Net earnings (loss) attributable to The Estée Lauder Companies Inc.	456	(6)	1,852	1,146
End of the period	11,420	10,595	11,420	10,595
Retained Earnings | Cumulative Effect, Period of Adoption, Adjustment
Increase (Decrease) in Stockholders' Equity
Beginning of the period	0	0	(3)	(29)
Accumulated Other Comprehensive Loss
Increase (Decrease) in Stockholders' Equity
Beginning of the period	(383)	(569)	(665)	(563)
Other comprehensive income (loss)	(104)	(143)	178	(149)
End of the period	(487)	(712)	(487)	(712)
Treasury Stock
Increase (Decrease) in Stockholders' Equity
Beginning of the period	(10,429)	(10,253)	(10,330)	(9,444)
Stock-based compensation	(1)	(2)	(100)	(108)
Acquisition of treasury stock	(212)	(65)	(212)	(768)
End of the period	(10,642)	(10,320)	(10,642)	(10,320)
Non-controlling Interests
Increase (Decrease) in Stockholders' Equity
Beginning of the period	35	27	27	25
Other comprehensive income (loss)	(1)	0	1	(1)
Net earnings attributable to noncontrolling interests	2	2	8	9
Distribution to noncontrolling interest holders	(6)	0	(6)	(4)
End of the period	$ 30	$ 29	$ 30	$ 29

EQUITY - Class of Stock and Div

EQUITY - Class of Stock and Dividend Information (Details) - $ / shares shares in Millions	Apr. 30, 2021	Mar. 15, 2021	Feb. 04, 2021	Dec. 15, 2020	Oct. 30, 2020	Sep. 15, 2020	Aug. 19, 2020	Mar. 31, 2021	Mar. 31, 2020	Mar. 31, 2021	Mar. 31, 2020
Class of Stock
Cash dividends declared per common share (in dollars per share)								$ 0.53	$ 0.48	$ 1.54	$ 1.39
Conversion of Class B to Class A (in shares)										4.6
Common Class A
Class of Stock
Cash dividends declared per common share (in dollars per share)			$ 0.53		$ 0.53		$ 0.48
Cash dividends paid per common share (in dollars per share)		$ 0.53		$ 0.53		$ 0.48
Common Class A | Subsequent Event
Class of Stock
Cash dividends declared per common share (in dollars per share)	$ 0.53
Common Class B
Class of Stock
Cash dividends declared per common share (in dollars per share)			$ 0.53		$ 0.53		$ 0.48
Cash dividends paid per common share (in dollars per share)		$ 0.53		$ 0.53		$ 0.48
Common Class B | Subsequent Event
Class of Stock
Cash dividends declared per common share (in dollars per share)	$ 0.53

EQUITY - Common Stock (Details)

EQUITY - Common Stock (Details) - Common Class A shares in Millions, $ in Millions	9 Months Ended
	Mar. 31, 2021USD ($)shares
Class of Stock
Stock repurchased during period (in shares) | shares	1.2
Stock repurchased during period | $	$ 316

EQUITY - Changes in Accumulated

EQUITY - Changes in Accumulated Other Comprehensive Income (Loss) (Details) $ in Millions	9 Months Ended
	Mar. 31, 2021USD ($)
Changes in AOCI, net of tax, by component
Balance, beginning of the period	$ 3,935
Balance, end of the period	5,528
Accumulated Other Comprehensive Loss
Changes in AOCI, net of tax, by component
Balance, beginning of the period	(665)
OCI before reclassifications	154
Amounts reclassified to Net earnings	24
Net current-period OCI	178
Balance, end of the period	(487)
Net Cash Flow Hedge Gain (Loss)
Changes in AOCI, net of tax, by component
Balance, beginning of the period	14
OCI before reclassifications	(22)
Amounts reclassified to Net earnings	10
Net current-period OCI	(12)
Balance, end of the period	2
Retirement Plan and Other Retiree Benefit Adjustments
Changes in AOCI, net of tax, by component
Balance, beginning of the period	(244)
OCI before reclassifications	1
Amounts reclassified to Net earnings	14
Net current-period OCI	15
Balance, end of the period	(229)
Translation Adjustments
Changes in AOCI, net of tax, by component
Balance, beginning of the period	(435)
OCI before reclassifications	175
Amounts reclassified to Net earnings	0
Net current-period OCI	175
Balance, end of the period	$ (260)

EQUITY - Reclassification Adjus

EQUITY - Reclassification Adjustments From Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Mar. 31, 2021	Mar. 31, 2020
Reclassification adjustments from accumulated other comprehensive income (loss)
Net sales	$ 3,864	$ 3,345	$ 12,279	$ 11,864
Interest expense	43	42	131	112
Earnings before income taxes	580	80	2,281	1,651
Benefit (provision) for deferred taxes	(122)	(84)	(421)	(496)
Net earnings (loss)	458	(4)	1,860	1,155
Amount Reclassified from AOCI
Reclassification adjustments from accumulated other comprehensive income (loss)
Net earnings (loss)	(10)	3	(24)	7
Gain (Loss) on Cash Flow Hedges | Amount Reclassified from AOCI
Reclassification adjustments from accumulated other comprehensive income (loss)
Earnings before income taxes	(8)	10	(13)	29
Benefit (provision) for deferred taxes	2	(2)	3	(7)
Net earnings (loss)	(6)	8	(10)	22
Gain (Loss) on Cash Flow Hedges | Foreign currency forward contracts | Amount Reclassified from AOCI
Reclassification adjustments from accumulated other comprehensive income (loss)
Net sales	(7)	10	(11)	29
Gain (Loss) on Cash Flow Hedges | Interest rate-related derivatives | Amount Reclassified from AOCI
Reclassification adjustments from accumulated other comprehensive income (loss)
Interest expense	(1)	0	(2)	0
Retirement Plan and Other Retiree Benefit Adjustments | Amount Reclassified from AOCI
Reclassification adjustments from accumulated other comprehensive income (loss)
Earnings before income taxes	(7)	(6)	(19)	(16)
Amortization of actuarial loss	(6)	(6)	(18)	(16)
Settlements	(1)	0	(1)	0
Benefit (provision) for deferred taxes	3	1	5	3
Net earnings (loss)	(4)	(5)	(14)	(13)
Cumulative Translation Adjustments | Amount Reclassified from AOCI
Reclassification adjustments from accumulated other comprehensive income (loss)
Gain on previously held equity method investment	0	0	0	4
Net earnings (loss)	0	0	0	(2)
Cumulative Translation Adjustments | Amount Reclassified from AOCI | Restructuring and other charges
Reclassification adjustments from accumulated other comprehensive income (loss)
Loss on liquidation of an investment in a foreign subsidiary	$ 0	$ 0	$ 0	$ (6)

STATEMENT OF CASH FLOWS (Detail

STATEMENT OF CASH FLOWS (Details) - USD ($) $ in Millions	9 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Cash:
Cash paid during the period for interest	$ 108	$ 94
Cash paid during the period for income taxes	435	472
Non-cash investing and financing activities:
Property, plant and equipment accrued but unpaid	68	47
Right-of-use assets obtained in exchange for new operating lease liabilities	$ 167	$ 216

SEGMENT DATA AND RELATED INFO_3

SEGMENT DATA AND RELATED INFORMATION (Details) $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2021USD ($)	Mar. 31, 2020USD ($)	Mar. 31, 2021USD ($)segment	Mar. 31, 2020USD ($)
SEGMENT DATA AND RELATED INFORMATION
Number of operating segments | segment			1
Net sales, before returns	$ 3,874	$ 3,345	$ 12,289	$ 11,864
Returns associated with restructuring and other activities	(10)	0	(10)	0
Net sales	3,864	3,345	12,279	11,864
Operating income (loss) before charges associated with restructuring and other activities:
Operating income (loss) before charges associated with restructuring activities	761	134	2,575	1,212
Operating income	616	109	2,384	1,149
Reconciliation:
Charges associated with restructuring and other activities	(145)	(25)	(191)	(63)
Interest expense	(43)	(42)	(131)	(112)
Interest income and investment income, net	9	14	40	41
Other components of net periodic benefit cost	(2)	(1)	(12)	(3)
Other income	0	0	0	576
Earnings before income taxes	580	80	2,281	1,651
The Americas
SEGMENT DATA AND RELATED INFORMATION
Net sales	916	892	2,837	3,278
Operating income (loss) before charges associated with restructuring and other activities:
Operating income (loss) before charges associated with restructuring activities	155	(217)	256	(571)
Europe, the Middle East & Africa
SEGMENT DATA AND RELATED INFORMATION
Net sales	1,706	1,525	5,276	5,281
Operating income (loss) before charges associated with restructuring and other activities:
Operating income (loss) before charges associated with restructuring activities	361	202	1,429	1,084
Asia/Pacific
SEGMENT DATA AND RELATED INFORMATION
Net sales	1,252	928	4,176	3,305
Operating income (loss) before charges associated with restructuring and other activities:
Operating income (loss) before charges associated with restructuring activities	245	149	890	699
Skin Care
SEGMENT DATA AND RELATED INFORMATION
Net sales, before returns	2,259	1,723	7,113	5,770
Operating income (loss) before charges associated with restructuring and other activities:
Operating income (loss) before charges associated with restructuring activities	804	418	2,453	1,822
Makeup
SEGMENT DATA AND RELATED INFORMATION
Net sales, before returns	1,018	1,146	3,243	4,249
Operating income (loss) before charges associated with restructuring and other activities:
Operating income (loss) before charges associated with restructuring activities	(72)	(283)	(115)	(790)
Fragrance
SEGMENT DATA AND RELATED INFORMATION
Net sales, before returns	454	349	1,478	1,392
Operating income (loss) before charges associated with restructuring and other activities:
Operating income (loss) before charges associated with restructuring activities	47	0	248	163
Hair Care
SEGMENT DATA AND RELATED INFORMATION
Net sales, before returns	128	119	418	417
Operating income (loss) before charges associated with restructuring and other activities:
Operating income (loss) before charges associated with restructuring activities	(17)	(2)	(10)	10
Other
SEGMENT DATA AND RELATED INFORMATION
Net sales, before returns	15	8	37	36
Operating income (loss) before charges associated with restructuring and other activities:
Operating income (loss) before charges associated with restructuring activities	$ (1)	$ 1	$ (1)	$ 7

SUBSEQUENT EVENTS (Details)

SUBSEQUENT EVENTS (Details) - USD ($)	1 Months Ended
	Apr. 30, 2021	Mar. 31, 2021
Subsequent Event | Interest rate swap contracts
Subsequent Event [Line Items]
Notional amount	$ 300,000,000
1.70% Senior Notes, due May 10, 2021 ("2021 Senior Notes")
Subsequent Event [Line Items]
Interest rate, stated percentage		1.70%
1.70% Senior Notes, due May 10, 2021 ("2021 Senior Notes") | Subsequent Event
Subsequent Event [Line Items]
Repayments of senior debt	$ 450,000,000
Interest rate, stated percentage	1.70%